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SUMMARY 
The integrity of the proteome is fundamental for cell viability. Proteins can misfold due 
to genetic mutations or environmental stress. These misfolded proteins have a high 
tendency to accumulate as toxic protein aggregates which are associated with several 
well-known pathologies like Alzheimer’s, Huntington’s or Parkinson’s disease. To 
prevent protein misfolding, cells have evolved several protein quality control 
mechanisms that monitor and preserve the integrity of the proteome.  
In this PhD thesis we have uncovered and characterized a stress-inducible protein 
degradation pathway in budding yeast (Saccharomyces cerevisiae) that targets 
misfolded but also native proteins in the cytosol and the endoplasmic reticulum (ER) 
membrane for degradation. We employed an ER membrane-anchored reporter protein 
harbouring a misfolded cytosolic domain that was selectively degraded by the 
proteasome under stress conditions. A genetic screen, performed prior to the start of 
the PhD project, found the ubiquitin E3 ligase Ubr1, the serine protease Ynm3 and an 
uncharacterized protein (Yjl144W, named Roq1 by us) to be required for the stress-
induced degradation of this misfolded model substrate. The three identified proteins 
act together in novel a linear protein degradation pathway, which we termed Stress-
induced Homeostatically Regulated Degradation (SHRED). Mechanistic analysis 
elucidated that the ROQ1 gene is transcriptionally upregulated during various stresses. 
The resulting Roq1 protein is cleaved by Ynm3, which uncovers a positively charged 
arginine residue on its N-terminus. Subsequently, cleaved Roq1 through its new N-
terminus interacts with Ubr1 and modulates its substrate specificity. Modified substrate 
recognition by Ubr1 enhances the proteasomal degradation of certain cytosolic and 
ER membrane proteins. Furthermore, a genetic screen and mass spectrometry 
analysis revealed endogenous candidate substrates of SHRED proposing that this 
pathway is not only implicated in quality control but also in quantity control of proteins. 
II 
 
 
 ________________________________________  ZUSAMMENFASSUNG 
III 
 
ZUSAMMENFASSUNG 
Die Integrität des Proteoms ist grundlegend für die Lebensfähigkeit von Zellen. 
Proteine können aufgrund von genetischen Mutationen oder Umweltstress fehlerhaft 
gefaltet werden. Diese fehlgefalteten Proteine haben eine hohe Tendenz sich als 
toxische Proteinaggregate anzusammeln, wie sie mit mehreren bekannten 
Pathologien wie der Alzheimer-, Huntington- oder Parkinson-Krankheit assoziiert sind. 
Um eine Fehlfaltung von Proteinen zu verhindern haben Zellen mehrere Mechanismen 
zur Kontrolle der Proteinqualität entwickelt, die die Integrität des Proteoms 
überwachen und bewahren. 
In dieser Doktorarbeit haben wir einen stressinduzierbaren Proteinabbauweg in 
Backhefe (Saccharomyces cerevisiae) entdeckt und charakterisiert, der sowohl 
fehlgefaltete als auch native Proteine im Cytosol und der Membran des 
Endoplasmatischen Retikulums (ER) für den Abbau markiert. Wir verwendeten ein in 
die ER-Membran verankertes Reporterprotein, das eine fehlgefaltete zytosolische 
Domäne beherbergt und dadurch unter Stressbedingungen selektiv vom Proteasom 
abgebaut wird. Ein genetischer Screen, der vor Beginn des PhD-Projekts durchgeführt 
wurde, identifizierte die Ubiquitin-E3-Ligase Ubr1, die Serinprotease Ynm3 und ein 
nicht charakterisiertes Protein (Yjl144W, von uns Roq1 genannt) als notwendig für den 
stressinduzierten Abbau dieses fehlgefalteten Modellsubstrats. Diese drei Proteine 
wirken in einem neuen linearen Proteinabbauweg zusammen, den wir als Stress-
induzierte homöostatisch regulierte Degradation (SHRED) bezeichneten. 
Mechanistische Analysen ergaben, dass das ROQ1-Gen während verschiedener 
Stresssituationen hochreguliert wird. Das resultierende Roq1-Protein wird durch Ynm3 
gespalten, was ein positiv geladenes Arginin an seinem N-Terminus freilegt. 
Anschließend interagiert Roq1 über seinen neuen N-Terminus mit Ubr1 und moduliert 
dessen Substratspezifität. Die modifizierte Ubr1-Substraterkennung steigert den 
Abbau bestimmter cytosolischer und ER-Membranproteine durch das Proteasom. 
Darüber hinaus deckten ein genetischer Screen und eine massenspektrometrische 
Analyse mögliche endogene Substrate von SHRED auf, was nahelegt, dass dieser 
Weg nicht nur in der Qualitätskontrolle, sondern auch in der Mengenkontrolle von 
Proteinen eine Rolle spielt. 
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INTRODUCTION 
The budding yeast (Saccharomyces cerevisiae) genome contains approximately 5800 
protein coding genes (Goffeau et al., 1996). In order to maintain the integrity of the 
proteome, protein synthesis, folding, and degradation have to be in equilibrium. The 
resulting balanced state of the proteome is called protein homeostasis. Perturbations 
in protein homeostasis, for example due to accumulation of misfolded proteins, lead to 
severe consequences, as observed in neurodegenerative diseases such as 
Alzheimer’s, Parkinson’s, Huntington’s and amyotrophic lateral sclerosis (Hartl, 2017). 
To maintain proper protein homeostasis, cells have evolved a delicate network of 
protein quality control (PQC) pathways. 
 
1.1 Protein quality control (PQC) 
Proteins can misfold due to stochastic fluctuations, genetic mutations or environmental 
stress (Hartl and Hayer-Hartl, 2009). Therefore, machineries involved in protein quality 
control pathways have three main tasks to perform: 1) selective recognition of 
misfolded proteins, 2) refolding of misfolded proteins and if the latter fails 3) removal 
of terminally misfolded proteins. Removal is achieved by either sequestration into 
subcellular protein deposits or degradation by the ubiquitin proteasome system (Chen 
et al., 2011). 
Selective recognition, refolding and sequestration of misfolded proteins is performed 
by molecular chaperones. Recognition is accomplished by the selective detection of 
surface exposed hydrophobic stretches, which are normally buried within the core of 
well-folded proteins (Balchin et al., 2016). 
The central players involved in the degradation of misfolded proteins are ubiquitin E3 
ligases. By binding misfolded proteins directly or indirectly with the aid of chaperones, 
they mark their substrates with a polyubiquitin chain for destruction by the proteasome 
(Zheng and Shabek, 2017).  
 
1.2 Molecular chaperones involved in PQC 
Molecular chaperones were originally defined as proteins that promote the folding of 
newly translated polypeptides but do not get incorporated into the final protein structure 
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(Ellis and van der Vies, 1991). Most of the molecular chaperones are called heat shock 
proteins (Hsp) due to their upregulation during elevated temperature. They are broadly 
categorized by their molecular weight resulting in the chaperone families of Hsp40, 
Hsp70, Hsp90, Hsp110 and small heat shock proteins. The highly conserved and best 
studied chaperones involved in PQC belong to the Hsp70 and Hsp90 chaperone family 
(Balchin et al., 2016; Kampinga and Craig, 2010). 
Folding is a highly energy-consuming process: ATP hydrolysis induces a 
conformational change in Hsp70 that enables substrate binding. Upon replacement of 
ADP with ATP, enhanced by nucleotide exchange factors, the substrate is released 
concluding an ATP-dependent folding cycle. Usually multiple folding cycles are 
required until a substrate protein reaches its final native conformation (Kim et al., 
2013).  
Hsp70s and Hsp90s can act alone or with the help of different cochaperones. For 
example, Hsp40 cochaperones can act as substrate adaptors: they selectively 
recognize un- or misfolded proteins and present them to Hsp70s for (re)folding. A 
single Hsp70 can interact with multiple different Hsp40s, which enables the recognition 
of a wide range of substrates. For example, the yeast Hsp70 Ssa1 can interact with 
either Ydj1 or Sis1 Hsp40 cochaperone. Ssa1 in complex with Ydj1 helps the refolding 
of misfolded proteins, while Ssa1 bound to Sis1 delivers misfolded proteins to 
intranuclear protein deposits (Becker et al., 1996; Horton et al., 2001; Miller et al., 
2015). Moreover, the interaction with Hsp40 promotes ATP hydrolysis in Hsp70, which 
further enhances its substrate binding capacity (Kampinga and Craig, 2010).  
An important role of molecular chaperones during PQC is triage decision, namely to 
refold, sequester or degrade misfolded proteins. The interaction of Hsp70 with different 
cochaperones can also influence triage decision. In mammalian cells the Hsp70 
chaperone Hsc70 interacts with different J-domain proteins (Hsp40s) to aid in the 
folding of un- or misfolded proteins (Kampinga and Craig, 2010). However, upon 
inefficient refolding the Hsc70 associates with the cochaperone CHIP, which promotes 
the ubiquitylation and subsequent degradation of the misfolded protein (Connell et al., 
2001).  
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1.3 Removal of misfolded proteins 
If refolding of misfolded proteins fails, cells must remove them to avoid severe 
consequences caused by the aggregation of misfolded proteins. One solution is the 
active sequestration of misfolded proteins into distinct subcellular protein deposits. The 
alternative option is the selective degradation of misfolded proteins by the ubiquitin 
proteasome system (UPS). 
1.3.1 Sequestration of misfolded proteins into protein deposits 
In yeast several protein deposits for misfolded proteins or aggregates exist: insoluble 
aggregates and β-sheet-rich amyloids are sequestered into compartments called 
insoluble protein deposits (IPOD) (Kaganovich et al., 2008). Misfolded and damaged 
proteins are initially sorted into dynamic Q-bodies prior to their degradation by the UPS 
(Escusa-Toret et al., 2013). If these misfolded proteins are not degraded immediately 
by the UPS they are sequestered into the juxtanuclear or intranuclear quality control 
compartment (JUNQ and INQ respectively) (Bagola and Sommer, 2008; Miller et al., 
2015). Additionally, several other protein deposits have been described in yeast 
including the endoplasmic reticulum (ER)-associated compartments, stress granules, 
peripheral aggregates and proteasome storage granules (Sontag et al., 2017). Some 
of the above-mentioned inclusions have overlapping functions and localization 
suggesting they are the same compartments but differently named (Sontag et al., 
2014). Taken together, some protein deposits are terminal destinations for 
aggregation-prone misfolded proteins, whereas others are formed transiently by 
misfolded proteins destined for the UPS. 
Originally, these inclusions were regarded as an indirect result of defective protein 
quality control. However, in recent years it has become evident that active 
sequestration of misfolded proteins and aggregates into distinct deposits is an early 
step in response to perturbations in protein homeostasis. For example, Q-bodies are 
proposed to form rapidly upon protein misfolding (Sontag et al., 2017). Hsp70s, 
together with their relevant cochaperones, serve central roles in delivering misfolded 
proteins to these deposits. For example, the chaperone Ssa1, together with its 
cochaperone Sis1, sorts misfolded proteins to INQ (Park et al., 2013). Similarly, the 
small heat shock protein Hsp42 is implicated in the formation of peripheral aggregates 
(Specht et al., 2011).  
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Importantly, sequestration to protein deposits is not necessarily the final destination of 
misfolded proteins. In yeast the Hsp104 disaggregase removes and unfolds 
polypeptides from protein aggregates in an ATP-dependent manner. These unfolded 
proteins are either refolded by downstream chaperones or degraded by the UPS 
(Glover and Lindquist, 1998). Alternatively, in metazoans protein aggregates have 
been shown to be removed by a selective autophagic process, called aggrephagy 
(Mogk et al., 2018; Zhang and Baehrecke, 2015).  
1.3.2. The ubiquitin proteasome system  
Selective destruction of misfolded proteins is achieved by the UPS. Ubiquitin is a 76 
amino acid protein that is found in all eukaryotes (Hershko and Ciechanover, 1998). 
Covalent modification of a target protein with ubiquitin is catalysed by a canonical 
cascade of E1, E2 and E3 enzymes. First the E1 enzyme activates ubiquitin in an ATP-
dependent manner and transfers it onto an active cysteine residue on the ubiquitin 
conjugating E2 enzyme. Subsequently, the ubiquitin E3 ligase mediates the formation 
of an isopeptide bond between a lysine residue on the target protein and the C-terminal 
glycine residue of ubiquitin (Varshavsky, 2012).  
In budding yeast, a single E1 enzyme is responsible for the activation of ubiquitin, while 
eleven different ubiquitin E2 conjugating enzymes mediate the next step in 
ubiquitylation. The most diverse and largest group in the ubiquitylation pathway is the 
family of ubiquitin E3 ligases. Their specific spatial and temporal localization, and 
selective interaction with target proteins offers the substrate specificity in the 
ubiquitylation process (Finley et al., 2012). 
The E3 enzymes are classified into two major groups: homologous to E6-AP carboxy 
terminus (HECT) domain E3s and really interesting new gene (RING) domain E3s. The 
two domains catalyse ubiquitylation in different ways: HECT E3s contain an active 
cysteine residue, which accepts the ubiquitin from an E2 enzyme before transferring it 
onto the target substrate (Scheffner et al., 1995). In contrast, RING E3s facilitate 
ubiquitin transfer by positioning the ubiquitin loaded E2 enzyme in close proximity of 
the target substrate protein (Metzger et al., 2014). RING domain-containing E3 
enzymes are further categorized by whether they bind their substrates directly (single 
subunit RING E3s) or through specialized substrate receptors and cofactors (multi-
subunit RING E3s).  
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Modification by ubiquitin is heterogenous. Attachment of a single ubiquitin 
(monoubiquitylation) or multiple single ubiquitin moieties to different acceptor lysine 
residues on the target protein (multiubiquitylation) mediate subcellular localization, 
trafficking or activity of target proteins. A polyubiquitin chain is formed by generating 
ubiquitin-ubiquitin conjugates using one of the seven acceptor lysine residues in 
ubiquitin. In general, the K48-linked polyubiquitin chain is the signal for proteasomal 
degradation (Kravtsova-Ivantsiv and Ciechanover, 2012; Yau and Rape, 2016). 
The destruction of polyubiquitylated substrates occurs in the proteasome. The 
proteasome is a multi-subunit macromolecular machine built up from the core particle 
and the regulatory particle. The core particle provides the proteolytic activity while the 
regulatory particle is responsible for the binding, deubiquitylation and unfolding of 
polyubiquitylated proteins. Substrates carrying a polyubiquitin chain are first 
recognised by ubiquitin receptors. Once the substrates are bound to the proteasome, 
deubiquitylating enzymes remove the polyubiquitin chain and ATPases unfold and feed 
the substrates into the catalytic core. After proteolysis the peptides of 5-7 amino acid 
length are released into the cytosol and further processed by cytosolic peptidases 
(Finley et al., 2016). 
 
1.4 Ubiquitin E3 ligases involved in PQC 
The ubiquitin ligase family comprises the most diverse group of enzymes in the 
ubiquitylation cascade. There are 60-100 predicted E3 ligases in budding yeast, 
however only a handful of them function in PQC pathways (Finley et al., 2012). These 
particular E3 ligases are part of spatially specified PQC pathways: namely the 
ribosomal, cytosolic, nuclear and ER protein quality control.  
1.4.1 E3 enzymes involved in ribosomal protein quality control 
Protein quality control at the ribosome involves the monitoring of polypeptides during 
the process of translation. Protein synthesis can be perturbed by translation from 
defective mRNAs lacking stop-codons or due to insufficient amount of tRNAs. All these 
perturbations lead to ribosome stalling. The ribosome-associated protein quality 
control pathway recognizes stalled ribosomes and initiate the degradation of erroneous 
nascent chains (Brandman and Hegde, 2016).  
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Ltn1 (also called Rkr1) is the crucial RING domain E3 ligase involved in the removal of 
aberrant polypeptides at the ribosome. It was originally identified through a genetic 
screen for factors involved in chromatin function and transcription (Braun et al., 2007). 
However, its more prominent role is in the polyubiquitylation of aberrant proteins 
translated from mRNAs lacking stop codons (Bengtson and Joazeiro, 2010). If 
translation cannot be terminated, due to the lack of a stop codon, the poly(A) tail on 
the mRNA is translated into a poly-lysine tract. This generates a highly positively 
charged sequence that electrostatically interacts with the negatively charged ribosome 
exit channel leading to ribosome stalling. Polyubiquitylation of aberrant nascent chains 
occurs while they are still associated with the 40S ribosome (Shao et al., 2013). How 
does Ltn1 recognize its substrates? One hypothesis is the direct recognition of the 
poly-lysine tract by Ltn1. Alternatively, translational pausing might induce 
conformational changes on the ribosome which could recruit Ltn1 directly or indirectly 
to the stalled ribosome to ubiquitylate nascent chains (Brandman et al., 2012).  
Recently it has been shown that degradation of ER-targeted model substrates without 
stop codons, is also dependent on Ltn1. Intriguingly, degradation of these substrates 
was not dependent on ER quality control factors Hrd1 and Doa10 (introduced below) 
(Crowder et al., 2015).  
1.4.2 E3 enzymes involved in cytosolic protein quality control 
The cytosol contains four known E3s involved in PQC. The RING domain E3 enzyme 
Ubr1 was the first ubiquitin ligase to be identified (Bartel et al., 1990). It was originally 
implicated in the N-end rule pathway, which determines the half-life of a protein based 
on the identity of the very N-terminal residue. In the N-end rule pathway, Ubr1 
selectively recognizes, binds to and ubiquitylates target proteins with destabilizing N-
terminal residues. Therefore, Ubr1 is also called N-degron (Varshavsky, 2011). 
However, Ubr1 is also implicated in the removal of cytosolic misfolded proteins. The 
cytosolic version of misfolded CPY*, a truncated and thus potentially misfolded soluble 
protein stGnd1 and unfolded cytosolic kinases are all Ubr1 substrates (Eisele and Wolf, 
2008; Heck et al., 2010; Nillegoda et al., 2010). 
How does Ubr1 recognize misfolded proteins? In vivo the cochaperones Sse1 or Sis1 
are required for the degradation of cytosolic misfolded proteins by Ubr1 (Heck et al., 
2010; Summers et al., 2013). Thus, Sse1 together with an Hsp70 is proposed to 
mediate PQC by presenting misfolded proteins to Ubr1. On the other hand, Ubr1 can 
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ubiquitylate denatured luciferase in vitro in the absence of chaperones. However, 
addition of Ssa1 to the reaction enhances the ubiquitylation reaction (Nillegoda et al., 
2010). Hence, Ubr1 is able to directly interact with and ubiquitylate misfolded proteins 
but molecular chaperones can aid ubiquitylation by presenting misfolded substrates to 
Ubr1.  
Intriguingly, Ubr1 is also involved in endoplasmic reticulum-associated degradation 
(ERAD). In the absence of the canonical ERAD E3 ligases Hrd1 and Doa10, the model 
ERAD substrate Ste6* is targeted by Ubr1. Moreover, ectopically expressed human 
cystic fibrosis transmembrane conductance regulator (CFTR), another model ERAD 
substrate, is also targeted by Ubr1 steady-state (Stolz et al., 2013). Taken together, 
Ubr1 is responsible for the removal of misfolded proteins from both the cytosol and the 
ER membrane. 
Ubr2 is a paralogue of Ubr1, however it is not involved in the N-end rule pathway 
(Hochstrasser, 1996). It is responsible for the ubiquitin-mediated degradation of Rpn4, 
the main transcription factor involved in proteasome biogenesis (Wang et al., 2004). 
Moreover, Ubr2 is implicated in maintaining the integrity of kinetochores, a large protein 
assembly formed at the centromeres of chromosomes during mitosis or meiosis 
(Akiyoshi et al., 2013; Herrero and Thorpe, 2016). Importantly, Ubr2 promotes the 
degradation of cytosolic misfolded kinases, however the mode of substrate interaction 
has not been determined (Nillegoda et al., 2010).  
Hul5 is one of only five HECT domain E3 ligases in yeast (Wang et al., 1999). Hul5 
directly interacts with the proteasome where it extends polyubiquitin chains on target 
proteins destined for degradation. The extension of the polyubiquitin chain is proposed 
to stabilize the interaction between proteasome and substrate leading to enhanced 
degradation of the latter (Crosas et al., 2006; Leggett et al., 2002). In addition, Hul5 is 
responsible for the degradation of misfolded proteins during heat shock (Fang et al., 
2011) and is also implicated in the degradation of ERAD substrates (Kohlmann et al., 
2008). However, how Hul5 recognizes misfolded proteins is currently unknown. 
Recently, another HECT domain E3 ligase, Rsp5 (Huibregtse et al., 1995) was 
identified as the main ubiquitin E3 ligase involved in the removal of misfolded proteins 
during heat shock (Fang et al., 2014). Rsp5 directly recognizes and interacts with PY 
motifs exposed upon heat shock (Fang et al., 2014). Moreover, Rsp5 is also 
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responsible for the degradation of many endogenous well-folded substrates involved 
in diverse biological pathways (Gupta et al., 2007).  
1.4.3 E3 enzymes involved in nuclear protein quality control 
San1, a RING domain E3 enzyme, is the only known ubiquitin ligase implicated in the 
removal of misfolded nuclear proteins (Dasgupta et al., 2004; Gardner et al., 2005). 
San1 directly recognizes short stretches of surface-exposed hydrophobic residues on 
misfolded proteins, which are prone to form aggregates (Fredrickson et al., 2013, 
2011). San1 is not only implicated in nuclear quality control: a genetic screen identified 
San1 to be important for the removal of misfolded cytosolic proteins as well (Heck et 
al., 2010). However, San1 is non-functional outside the nucleus. This suggests that the 
misfolded cytosolic substrates are actively delivered into the nucleus by the 
cochaperone Sse1 for San1-mediated ubiquitylation and degradation (Gardner et al., 
2005; Heck et al., 2010; Prasad et al., 2010).  
1.4.4 E3 enzymes involved in ER quality control 
Recognition and degradation of misfolded ER luminal or membrane proteins is 
achieved by the ERAD machinery. In the core of these machines are the ubiquitin E3 
ligases, which form a complex with cofactors and substrate adaptors to recognize and 
ubiquitylate ERAD substrates (Berner et al., 2018). The Hrd1 complex is responsible 
for misfolded proteins/domains in the lumen or in the membrane-spanning region 
(ERAD-L and ERAD-M pathway, respectively), while the Doa10 complex recognizes 
and ubiquitylates proteins with cytosolic misfolded domains (ERAD-C pathway) (Bays 
et al., 2001; Carvalho et al., 2006; Deng and Hochstrasser, 2006). Recently the Asi1-
3 complex has been described in yeast to monitor and degrade misfolded or 
mislocalized proteins of the inner nuclear membrane (INM), which is an ER subdomain 
(Foresti et al., 2014; Khmelinskii et al., 2014). 
Hrd1 (also called Der3) is a multi-membrane spanning RING domain E3 ligase. It was 
identified in two independent genetic screens using either Hmg2, a key enzyme in 
sterol biosynthesis, or luminal CPY* as a model substrate (Bordallo et al., 1998; 
Hampton et al., 1996; Knop et al., 1996). Further experiments revealed that Hrd1 is 
part of a complex of at least six subunits (Ruggiano et al., 2014). The entire complex 
is responsible for the recognition and ubiquitylation of misfolded proteins and for their 
retrotranslocation from the ER lumen or membrane into the cytosol for proteasomal 
degradation (Schoebel et al., 2017). Recognition of ERAD-L substrates is 
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accomplished by the luminal Hsp70 Kar2 and the lectin Yos9. The recognized 
misfolded proteins are delivered to Hrd1 via a single membrane-spanning protein Hrd3, 
which interacts simultaneously with both Hrd1 and Kar2 or Yos9 (Denic et al., 2006). 
Moreover, Der1, another membrane protein in the Hrd1 complex, has been implicated 
in the recognition of ERAD-L substrates (Knop et al., 1996; Stanley et al., 2011). In 
contrast to ERAD-L substrates, degradation of ERAD-M substrates is only dependent 
on Hrd1 and Hrd3 and partially on Usa1, a scaffold protein in the Hrd1 complex 
(Carvalho et al., 2006; Horn et al., 2009). Hrd1 is proposed to interact directly with 
ERAD-M substrates through hydrophilic residues in the Hrd1 membrane spanning 
domains (Sato et al., 2009). Taken together the Hrd1 complex is a huge modular 
complex that is capable of substrate recognition in a multitude of ways (Kanehara et 
al., 2010).  
Doa10 is a RING domain E3 ligase with multiple membrane spanning domains. It was 
identified in a genetic screen for the degradation of a soluble transcriptional repressor 
(Swanson et al., 2001). Intriguingly, it localizes to the INM where it ubiquitylates soluble 
nuclear proteins for degradation (Deng and Hochstrasser, 2006). However, Doa10 is 
not only restricted to ERAD-C substrates. Recently it has been implicated in the 
degradation of an ERAD-M substrate, Sbh2 (Habeck et al., 2015). How does Doa10 
recognize its substrates? Similarly to Hrd1, Doa10 also contains hydrophilic residues 
within its membrane domain suggesting an analogous mode of ERAD-M substrate 
recognition (Habeck et al., 2015). On the other hand, how Doa10 recognizes ERAD-C 
substrates is currently unknown. Doa10 does not interact with substrate adaptor 
proteins like Hrd3 suggesting that Doa10 might directly interact with ERAD-C 
substrates (Deng and Hochstrasser, 2006). 
The Asi1-3 complex contains two RING domain E3 enzymes Asi1/Asi3 and a bridging 
subunit Asi2. The Asi1-3 complex localizes to the INM and targets misfolded or 
mislocalized ERAD-M substrates in the nuclear envelope. Asi2 is proposed to function 
as a substrate adaptor in the complex, however, how the Asi1-3 complex work 
mechanistically is yet to be investigated (Foresti et al., 2014; Khmelinskii et al., 2014).  
In summary, the different subcellular compartments all have their own dedicated E3 
ligase(s) for the removal of misfolded or damaged proteins. However, the 
compartmentalization is not strict, as several E3s regulate quality control mechanisms 
in multiple subcellular locations. 
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1.5 Stress response pathways that modulate PQC 
During stress, protein folding is compromised and therefore cells trigger adaptive 
responses to upregulate PQC pathways. For example, protein misfolding in the ER 
triggers the unfolded protein response (UPR), which upregulates the expression of 
molecular chaperones and the ERAD components to alleviate ER stress (Walter and 
Ron, 2011). Similarly, protein misfolding in the cytosol activates the heat shock 
response (HSR) to induce the expression of cytosolic quality control factors (Labbadia 
and Morimoto, 2015). 
1.5.1 The unfolded protein response (UPR) 
All proteins entering the ER obtain their final conformation in the ER membrane and 
the ER lumen before they are delivered to their final destination along the secretory 
pathway (Braakman and Hebert, 2013). If folding is delayed or an illegitimate 
conformation arises, the substrate is either subjected to additional folding cycles or is 
selected for degradation by ERAD. Collectively, the UPR is responsible for the 
monitoring of all proteins entering the ER (Ron and Walter, 2007). 
In metazoans there are three branches of UPR signalling. The main regulators of each 
branches are ER-localized membrane proteins namely IRE1, PERK and ATF6. The 
highly conserved Ire1 branch was the first to be identified and the only UPR signal 
transducer in budding yeast (Walter and Ron, 2011). Ire1 is a bifunctional enzyme 
containing both kinase and endoribonuclease activity (Cox et al., 1993; Nikawa and 
Yamashita, 1992). Upon activation, Ire1 cleaves the mRNA of the UPR transcription 
factor Hac1 at two specific sites (Sidrauski and Walter, 1997). The cleaved mRNA is 
subsequently ligated by the tRNA ligase Trl1 (Sidrauski et al., 1996) and translated 
into the active version of spliced Hac1 (Hac1s). Hac1s specifically binds to UPR 
response elements in the promoter region of target genes and activates their 
transcription (Mori et al., 1996). The main UPR transcriptional targets are involved in 
protein translocation, folding, modification of nascent chains and degradation of 
misfolded proteins via ERAD to alleviate ER stress (Travers et al., 2000).  
In the absence of protein folding stress Ire1 is in a monomeric “resting” state. Upon 
accumulation of misfolded proteins in the ER lumen Ire1 forms back-to-back dimers 
which leads to trans-phosphorylation and formation of higher order oligomers 
(Korennykh et al., 2009; Lee et al., 2008). In this oligomeric state Ire1 endonuclease 
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activity is induced resulting in the cleavage of the HAC1 mRNA. How does Ire1 
recognize misfolded proteins? The classical model proposes that steady-state Kar2 
interacts with Ire1, which retains Ire1 in an inactive monomeric state. Upon 
accumulation of misfolded proteins Kar2 dissociates from Ire1 which leads to its 
activation (Ron and Walter, 2007). However, Ire1 mutants that are unable to bind Kar2 
can still induce UPR (Kimata et al., 2004). In the alternative model, direct binding of 
misfolded proteins to the luminal domain of Ire1 activates the UPR. This model is based 
on the identification of a peptide binding groove on the luminal domain of Ire1 by 
crystallography (Credle et al., 2005). The two models are not mutually exclusive, thus 
in a third hybrid model, activation via both Kar2 dissociation and direct interaction with 
misfolded proteins is also plausible. Moreover, Ire1 can be activated by aberrant 
membrane lipid composition as well (Halbleib et al., 2017; Promlek et al., 2011). 
Therefore, Ire1 is not only sensing unfolded protein stress but also lipid bilayer stress. 
1.5.2 The heat shock response (HSR) 
As its name suggests, the HSR was initially described as an adaptive response to 
elevated temperature. The cellular response to heat shock is multifaceted, which 
involves cell cycle arrest, metabolic reprogramming and alterations in membrane and 
cell wall dynamics. Moreover, it involves the reprogramming of PQC pathways as a 
response to increased proteotoxicity caused by the accumulation of misfolded and 
damaged protein during heat shock (Verghese et al., 2012). Intriguingly, in budding 
yeast the accumulation of misfolded proteins only occurs upon severe heat shock 
(45°C or higher), while cells kept at 37°C do not show any hallmarks of protein 
misfolding even in the absence of Hsp90 (Fang et al., 2011; Nathan et al., 1997). This 
suggests that during mild heat shock the plasticity of the PQC pathways is capable to 
efficiently cope with the perturbation in protein homeostasis. Importantly, HSR is not 
only activated by elevated temperature but also upon accumulation of cytosolic 
misfolded proteins (Labbadia and Morimoto, 2015).  
On the molecular level the initial step in HSR is the upregulation of heat shock proteins 
which are mostly but not exclusively molecular chaperones (Verghese et al., 2012). In 
budding yeast, the HSR is regulated by a single essential transcriptional factor Hsf1 
(Sorger and Pelham, 1988; Wiederrecht et al., 1988). Hsf1 directly binds to promoter 
regions with heat shock transcription elements and activates the transcription of the 
downstream gene. In non-stressed mammalian cells, Hsf1 is kept in an inactive 
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monomeric state by a constitutively expressed Hsp70 and its cochaperone Hdj1 (Shi 
et al., 1998). Upon heat shock or accumulation of misfolded proteins in the cytosol, 
Hsf1 is released, trimerizes and translocates into the nucleus where it upregulates 
transcription of target genes (Baler et al., 1993). When stress subsides, Hsf1 is 
acetylated and repressed by molecular chaperones (Raychaudhuri et al., 2014). 
Besides transcriptional upregulation of the HSP genes, the HSR also upregulates the 
UPS. The latter was deduced from the increased total amount of ubiquitin conjugates 
and elevated proteasomal degradation upon heat shock (Medicherla and Goldberg, 
2008; Parag et al., 1987). The main UPS members involved in the clearance of 
misfolded or damaged proteins upon heat shock are Rsp5 and Hul5 (Fang et al., 2014). 
1.5.3 The environmental stress response (ESR) 
Unicellular organisms like budding yeast are exposed to sudden changes in the 
environment including fluctuations in temperature, osmolarity, acidity or in nutrient 
availability. In order to cope with these fluctuations, yeast induces a general stress 
response pathway, called ESR, which reprograms the expression pattern of 
approximately 900 genes with one third of them being transcriptionally upregulated and 
two thirds being downregulated (Causton et al., 2001; Gasch et al., 2000). In general, 
the induced genes are implicated in protein folding, protein degradation, autophagy 
and DNA-damage repair amongst others (Gasch, 2003). Conversely, downregulated 
genes are mainly involved in general protein translation including genes involved in 
ribosome or tRNA synthesis, general transcription and in mRNA processing and export 
(Gasch, 2003). Importantly, the ESR is not specific to a certain stressor but instead 
offers a common response to re-establish the cellular homeostasis (Gasch, 2003). 
The main transcription factors governing the ESR pathway are Msn2/4 and Hsf1. 
Msn2/4 is negatively regulated by the protein kinase A, which in yeast is built up from 
three subunits namely Tpk1/Tpk2/Tpk3 (Toda et al., 1987). The activity of the Tpk 
complex is regulated by its inhibitor Bcy1. Upon production of cAMP Bcy1 dissociates 
from the Tpk1 and Tpk2 subunit resulting in the activation of the Tpk complex 
(Thevelein and De Winde, 1999). The active complex phosphorylates Msn2/4 which 
blocks their nuclear entry, and therefore prevents them from transcriptional regulation 
(Görner et al., 1998). Upon Tpk inactivation Msn2/4 relocalizes to the nucleus and 
binds to stress response elements in promoter regions to upregulate transcription. 
Importantly, the HSR is a branch of the ESR, which means that nearly all HSR target 
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genes are upregulated during ESR activation through Hsf1 (Verghese et al., 2012). 
However, regulation of Hsf1 during ESR induction is not as well established as its 
regulation during HSR. In vitro studies propose that both Yak1 and Rim15 kinase 
directly phosphorylate Hsf1, which is required for its activation and DNA binding 
capability during ESR (Lee et al., 2013; P. Lee et al., 2008). However, no clear in vivo 
data is available on the role of Yak1 and Rim15 on Hsf1 activation.  
 
1.6 Aim of the study 
Protein quality control pathways in the ER, the cytoplasm or in the nucleus are well-
studied fields of molecular biology and biochemistry. However, much less is known 
about how cells maintain protein homeostasis on the interface of different subcellular 
compartments. The main aim of this PhD thesis was to investigate how cells recognize 
and degrade ER membrane proteins with a cytoplasmic misfolded domain during 
stressful conditions. To achieve this aim, we employed an ER-anchored misfolded 
reporter protein that is selectively degraded under stress conditions. A genetic screen, 
performed prior to the start of the PhD project, identified three relevant genes that are 
required for the stress-induced degradation of this misfolded reporter. The specific 
aims of the study were the following: 
 
1) Characterization of the stress-induced degradation phenotype of an ER-anchored 
misfolded reporter protein 
2) Mechanistic analysis of the stress-induced protein degradation pathway identified 
by the genetic screen 
3) Determining the substrate spectrum of the stress-induced protein degradation 
pathway
 14 
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RESULTS 
2.1 Misfolded reporter proteins to follow PQC mechanisms at the ER 
membrane 
2.1.1 Generation and characterization of misfolded ER reporter proteins 
In order to follow the fate of ER membrane proteins with cytosolic misfolded domains, 
three reporter proteins were generated. The reticulon protein Rtn1 was used to anchor 
the reporter to the ER membrane (Oertle et al., 2003). Rtn1 is inserted into the ER 
membrane via two reticulon homology domains (RHD) and both the N- and C-terminus 
face the cytosol (De Craene et al., 2006; Voeltz et al., 2006). The RHD is an 
approximately 35 amino acid long hydrophobic segment that forms a hairpin inside the 
membrane without passing the lipid bilayer (Brady et al., 2015). Thus, none of the 
reporter protein is visible from the lumen of the ER, which allows its uncoupling from 
any ER luminal quality control pathways (i.e. the UPR). Two mutated proteins CPY* 
and Pho8* were attached to the C-terminus of Rtn1 to create misfolded cytosolic 
domains (Figure 1A). CPY* is a mutant version of the vacuolar caboxypeptidase yscY 
(Finger et al., 1993; Wolf and Fink, 1975), which is continuously degraded by the 
proteasome via the Hrd1-mediated ERAD-L pathway (Bordallo et al., 1998; Hiller et 
al., 1996). Pho8*, generated by Sebastian Schuck, is a truncated and point mutant 
version of the vacuolar phosphatase Pho8. When expressed in the ER lumen, it is 
degraded via Hrd1 (Figure 1B). Additionally, expressing Pho8* in the cytosol leads to 
its constitutive San1-mediated degradation suggesting that it is misfolded (Figure 1C). 
In order to visually follow the turnover of these reporter proteins, GFP was fused to the 
C-terminus generating the reporter proteins Rtn1CPY*-GFP and Rtn1Pho8*-GFP. 
Rtn1-GFP, the reporter protein with no misfolded domain, was used as negative 
control.  
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Figure 1. Pho8(F352S) is a misfolded protein 
A) Schematic illustration of the reporter proteins used in the thesis. B) Western blot of Pho8 and Pgk1 
from wild-type (WT) or hrd1∆ cells expressing wild-type Pho8 or point mutant Pho8(F352S). Pgk1 
served as loading control. pPho8 – enzymatically inactive Pho8 precursor, mPho8 – mature Pho8 in 
the vacuole membrane, sPho8 – mature soluble Pho8 inside the vacuole. Experiment performed by 
Katharina Schaeff. C) Western blot of Pho8 and Pgk1 after cycloheximide (CHX) treatment of WT or 
san1∆ cells expressing cytosolic Pho8*-GFP. Pgk1 served as loading control. mPho8 – mature 
endogenous Pho8 in the vacuole membrane. Experiment performed by Katharina Schaeff. 
 
The three reporters were integrated into the genome via homologous recombination 
and expressed from a constitutive ADH1 promoter unless noted otherwise. Subcellular 
fractionation confirmed their proper membrane insertion (Figure 2A). Importantly, the 
reporters overlapped with the general ER membrane marker Sec63-mCherry 
confirming their ER localization (Figure 2B).  
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2.1.2 Degradation phenotype of 
Rtn1Pho8*-GFP 
In order to determine the stability of 
the reporters, their steady-state 
turnover was compared to the 
turnover of the well-studied ERAD 
substrate Hmg2 (Hampton and 
Rine, 1994). Hmg2-GFP was 
degraded rapidly resulting in a half-
life of approximately 30 minutes in 
a cycloheximide chase experiment 
(Figure 3A, B). As expected, Rtn1-
GFP was stable throughout the 
treatment (Christiano et al., 2014). 
However, Rtn1CPY*-GFP was 
continuously degraded with a half-
life of roughly two hours. 
Surprisingly, Rtn1Pho8*-GFP 
showed the same stability as Rtn1-
GFP during four hours of 
cycloheximide chase despite its 
misfolded domain (Figure 3A, B). 
This unexpected finding motivated 
us to further investigate and 
characterize the degradation 
phenotype of Rtn1Pho8*-GFP. 
Figure 2. The reporter proteins localize to the ER 
membrane 
A) Western blot of GFP, Sec61 and Pgk1 after 
subcellular fractionation of wild-type cells expressing 
Rtn1-GFP, Rtn1CPY*-GFP or Rtn1Pho8*-GFP. Sec61 
and Pgk1 served as markers for membrane proteins and 
soluble proteins, respectively. T – total lysate, S – 
supernatant fraction, P – pellet fraction. B) Fluorescent 
microscopy images of wild-type cells expressing 
endogenously tagged Sec63-mCherry and Rtn1-GFP, 
Rtn1CPY*-GFP or Rtn1Pho8*-GFP. Overexpression of 
the Rtn1-based reporters induced the formation of bright 
punctae at the cell periphery (arrowheads). This 
phenotype is often detected upon Roq1 overexpression 
and it reflects over-tubulated ER (Voeltz et al., 2006). 
Scale bar: 2 µm.  
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Figure 3. Rtn1Pho8*-GFP is a stable protein steady-state 
A) Western blot of GFP or total GFP fluorescence B), measured by flow cytometry, after 
cycloheximide treatment of wild-type cells expressing Hmg2-GFP, Rtn1-GFP, Rtn1CPY*-GFP or 
Rtn1Pho8*-GFP. Mean ± SEM, n = 5. The experiment in (A) was performed by Katharina Schaeff. 
 
Stress conditions are known to upregulate different quality control pathways (Higuchi-
Sanabria et al., 2018). Therefore, the stability of Rtn1Pho8*-GFP was tested under 
ER-stress conditions. Tunicamycin, an often-used ER-stressor, blocks N-glycosylation 
in the ER lumen, which leads to protein misfolding and eventually ER-stress (Gerlach 
et al., 2012). Five hours of tunicamycin treatment caused the selective degradation of 
Rtn1Pho8*-GFP driven from a constitutive ADH1 promoter (Figure 4A, B). The slight 
drop in Rtn1-GFP levels during tunicamycin treatment probably reflects the 
transcriptional downregulation of the ADH1 promoter upon ER-stress (Pincus et al., 
2014). Since both reporters were expressed from the ADH1 promoter, the excessive 
drop of Rtn1Pho8*-GFP levels, compared to Rtn1-GFP, is likely to reflect selective 
protein degradation. In order to confirm this, degradation of the reporter was followed 
in a chase experiment. Since tunicamycin inhibits N-glycosylation of newly synthesized 
proteins and thus requires ongoing protein synthesis to be effective, a combination of 
cycloheximide and tunicamycin treatment is not feasible. To bypass this limitation, the 
reporters were expressed from an inducible GAL1 promoter in galactose-containing 
medium followed by promoter shut-off by diluting the cells back into glucose-containing 
medium. After promoter shut-off the levels of both reporters remained stable in 
agreement with the cycloheximide chase. In contrast, Rtn1Pho8*-GFP levels dropped 
substantially during four hours of tunicamycin treatment while Rtn1-GFP levels showed 
only a minor drop (Figure 4C).  
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Figure 4. Rtn1Pho8*-GFP is degraded upon ER stress 
A) Western blot of GFP and Pgk1 or mean GFP fluorescence B), measured by flow cytometry, after 
tunicamycin (Tm) treatment of wild-type cells expressing Rtn1-GFP or Rtn1Pho8*-GFP. Pgk1 served 
as loading control. Mean ± SEM, n = 4. The experiment in (A) was performed by Kevin Leiss. C) Total 
GFP fluorescence, measured by flow cytometry, after promoter shut-off and tunicamycin treatment of 
wild-type cells expressing GAL1-driven Rtn1-GFP or Rtn1Pho8*-GFP. Mean ± SEM, n = 4.  
 
Galactose-induced reporters also localized to the ER membranes and subcellular 
fractionation confirmed their membrane association (Figure 5A, B). Thus, ER-stress 
triggers the selective degradation of pre-existing ER-localized misfolded Rtn1Pho8*-
GFP. 
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Figure 5. GAL1-driven reporters localize to the ER membrane 
A) Fluorescent microscopy images of wild-type cells expressing endogenously tagged Sec63-
mCherry and GAL1-driven Rtn1-GFP or Rtn1Pho8*-GFP. Scale bar: 2 µm. B) Western blot of GFP, 
Sec61 and Pgk1 after subcellular fractionation of wild-type cells expressing GAL1-driven Rtn1-GFP 
or Rtn1Pho8*-GFP. Sec61 and Pgk1 served as markers for membrane proteins and soluble proteins, 
respectively. T – total lysate, S – supernatant fraction, P – pellet fraction. 
 
2.1.3 Rtn1Pho8*-GFP is degraded by the proteasome  
There are two sites of protein degradation in yeast: the vacuole (the equivalent of 
mammalian lysosomes) and the proteasome. Inhibition of the vacuolar serine 
proteases by PMSF or the proteasome by MG132 slowed down the tunicamycin-
induced degradation of Rtn1Pho8*-GFP (Figure 6A, B). This suggested that the 
reporter is degraded in both compartments. However, combined addition of the drugs 
resulted only in a minor additive effect. Moreover, deletion of the two major vacuolar 
proteases Pep4 and Prb1 (Teichert et al., 1989) had no effect on reporter degradation 
(Figure 6A, B). Since PMSF is a non-selective serine protease inhibitor, it most likely 
inhibited additional serine proteases outside the vacuole that are required for 
Rtn1Pho8*-GFP degradation. Indeed, addition of PMSF in pep4∆ prb1∆ cells led to 
impaired stress-induced degradation of Rtn1Pho8*-GFP (Figure 6A, B). Intriguingly, 
degradation was also not affected by the deletion of ERAD components Hrd1 and 
Doa10 (Figure 6C). Hence, ER-stress induces the proteasomal degradation of 
Rtn1Pho8*-GFP independent of Hrd1- or Doa10-mediated ERAD.  
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Figure 6. Rtn1Pho8*-GFP is degraded by the proteasome independent of Hrd1/Doa10 
A) Western blot of GFP and Pgk1 or mean GFP fluorescence B), measured by flow cytometry, of 
pdr5∆ (wild-type, WT) or pep4∆ prb1∆ cells expressing Rtn1Pho8*-GFP after tunicamycin (Tm), 
MG132 or PMSF treatment where indicated. Pgk1 served as loading control. Mean ± SEM, n = 3. 
C) Mean GFP fluorescence, measured by flow cytometry, after tunicamycin treatment of hrd1∆ 
doa10∆ cells expressing Rtn1Pho8*-GFP. Mean ± SEM, n = 3. 
 
2.1.4 A genetic screen to uncover the degradation machinery of Rtn1Pho8*-GFP 
These intriguing findings raised the question of which genes/proteins are required for 
the stress-induced degradation of Rtn1Pho8*-GFP. In order to uncover the 
degradation machinery Sebastian Schuck, Enrique Garcia-Rivera, Vivian Chen and 
Dale Muzzey performed a random mutagenesis screen. Briefly, wild-type cells 
harbouring Rtn1Pho8*-GFP were mutagenized with ethyl methanesulfonate and 
screened by flow cytometry for mutants that were unable to degrade Rtn1Pho8*-GFP 
during tunicamycin treatment. Subsequent complementation analysis and whole 
genome sequencing uncovered mutations in five relevant genes: PRE2, UMP1, UBR1, 
YNM3/NMA111 and YJL144W.  
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PRE2 is an essential gene that encodes the β5 subunit of the 20S proteasome and is 
responsible for its chymotryptic activity (Heinemeyer et al., 1993). The random 
mutagenesis screen uncovered a viable but hypomorphic mutant allele coding 
Pre2(D243N). Ump1 is a short-lived chaperone required for the correct maturation of 
the 20S proteasome. Upon completion of the assembly Ump1 itself is degraded by the 
proteasome (Ramos et al., 1998). The requirement for these two factors supports the 
notion that Rtn1Pho8*-GFP is degraded via the proteasome.  
Ubr1 was the first ubiquitin E3 ligase to be identified and it is mainly implicated in the 
N-end rule pathway (Bartel et al., 1990). Moreover, it has an emerging role in targeting 
misfolded proteins for degradation (Eisele and Wolf, 2008; Heck et al., 2010; Nillegoda 
et al., 2010), which is in line with its identification through the screen. Ynm3 is the only 
budding yeast homologue of the HtrA-like (high-temperature requirement A) serine-
protease family (Fahrenkrog et al., 2004), providing an explanation for the sensitivity 
of reporter degradation to PMSF treatment (Clausen et al., 2011). YJL144W codes for 
an uncharacterized protein whose plant homologues appear to counteract protein 
aggregation during desiccation (Garay-Arroyo et al., 2000). Due to its role in protein 
quality control (see below) we have named this gene Regulator of Quality Control 
(ROQ1).  
2.1.5 Validation of the random mutagenesis screen 
The identification of Ubr1 agrees with its known function in protein quality control. 
However, its stress-regulation is less established (Stolz et al., 2013). On the other 
hand, Ynm3 and Roq1 had not been implicated in protein quality control. Hence, 
throughout the rest of the PhD thesis the function of UBR1, YNM3 and ROQ1 was 
investigated in the context of stress-induced protein quality control.  
Individual deletion of UBR1, YNM3 or ROQ1 did not show any growth defect on agar 
plates or in liquid culture (Figure 7A, B). However, tunicamycin-induced Rtn1Pho8*-
GFP degradation was delayed in ubr1∆, ynm3∆ and roq1∆ strains (Figure 7C). The 
same degradation phenotype was observed when dithiothreitol (DTT), a reducing 
agent that prevents disulfide bridge formation in the ER lumen, was used as an ER-
stressor (Figure 7D). The residual drop in the mutant strains might reflect the 
transcriptional downregulation of the reporter (see above) and/or the involvement of 
other redundant pathways or proteins. Importantly, degradation of pre-existing 
galactose-induced Rtn1Pho8*-GFP was also dependent on UBR1, YNM3 and ROQ1 
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(Figure 7E). To note, UBR1 deletion presented a stronger phenotype on the stress-
induced degradation of Rtn1Pho8*-GFP compared to the deletion of YNM3 and ROQ1. 
This phenotype suggests that during stress, Ubr1 acts in additional quality control 
pathways as well. Hence, through the random mutagenesis screen we have uncovered 
a new quality control pathway that degrades proteins with misfolded cytosolic domains 
at the ER membranes during stress. We termed this pathway Stress-induced 
Homeostatically Regulated Degradation (SHRED).  
 
Figure 7. SHRED is required for Rtn1Pho8*-GFP degradation upon ER stress (legend on the 
following page) 
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Figure 7. SHRED is required for Rtn1Pho8*-GFP degradation upon ER stress 
A) Five-fold dilution steps of wild-type (WT), ubr1∆, ynm3∆ and roq1∆ cells on YPD agar plates. B) 
Growth of WT, ubr1∆, ynm3∆ and roq1∆ cells in SC media. Area under a 24-hour growth curve is 
plotted in arbitrary units. n = 1. C, D) Mean GFP fluorescence, measured by flow cytometry, after 
tunicamycin (C) or DTT (D) treatment of WT, ubr1∆, ynm3∆ and roq1∆ cells expressing Rtn1Pho8*-
GFP. Mean ± SEM, n = 5. E) Total GFP fluorescence, measured by flow cytometry, after promoter 
shut-off and tunicamycin treatment of WT, ubr1∆, ynm3∆ and roq1∆ cells expressing GAL1-driven 
Rtn1Pho8*-GFP. Mean ± SEM, n = 5. 
 
 
2.2 Characterization of SHRED 
2.2.1 SHRED is a linear pathway 
After confirming the requirement for UBR1, YNM3 and ROQ1 in SHRED, we tested 
whether they act in a linear pathway. The deletion of two of these genes in any 
combination resulted in a similar degradation phenotype as in the single deletion 
background suggesting that they are epistatic with one another (Figure 8A, B). 
Proteasome inhibition in ubr1∆, ynm3∆ or roq1∆ background did not show any 
additional effect indicating that SHRED is the only proteasomal degradation pathway 
the reporter is subjected to (Figure 8C). Furthermore, PMSF treatment in ynm3∆ 
background did not have an additional effect suggesting that the sole serine protease 
required for SHRED is Ynm3 (Figure 8D). 
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Figure 8. SHRED is a linear pathway 
A) Western blot of GFP and Pgk1 from wild-type (WT), ubr1∆, ynm3∆, roq1∆, ubr1∆ ynm3∆, ubr1∆ 
roq1∆ and ynm3∆ roq1∆ cells expressing Rtn1Pho8*-GFP after four hours of tunicamycin (Tm) 
treatment where indicated. Pgk1 served as loading control. B) As in A) but mean GFP fluorescence 
of cells, measured by flow cytometry, after tunicamycin treatment. Mean ± SEM, n = 5. C) Mean GFP 
fluorescence, measured by flow cytometry, after tunicamycin or tunicamycin and MG132 treatment of 
pdr5∆ (WT), pdr5∆ ubr1∆ (ubr1∆), pdr5∆ ynm3∆ (ynm3∆), pdr5∆ roq1∆ (roq1∆) cells expressing 
Rtn1Pho8*-GFP. Mean ± SEM, n = 3. D) Mean GFP fluorescence, measured by flow cytometry, after 
tunicamycin or tunicamycin and PMSF treatment of WT or ynm3∆ cells expressing Rtn1Pho8*-GFP. 
Mean ± SEM, n = 4.  
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2.2.2 Additional genes required for SHRED 
It is known that certain quality control factors act in multiple protein quality pathways 
(see Introduction) (Prasad et al., 2010; Stolz et al., 2013). Hence, we tested other 
quality control factors for thier potential role in SHRED. Rad6, the ubiquitin-conjugating 
E2 enzyme of Ubr1 (Dohmen et al., 1991), was required for the degradation of 
Rtn1Pho8*-GFP. However, neither the cytosolic ubiquitin E3 ligase Ubr2 
(Hochstrasser, 1996; Wang et al., 2004) nor the nuclear E3 ligase San1 (Dasgupta et 
al., 2004), was required for reporter degradation (Figure 9A). The minor effect of SAN1 
deletion on Rtn1Pho8*-GFP degradation is probably indirect since there was no 
additional effect in the ubr1∆ san1∆ strain compared to ubr1∆ alone (Figure 9A). Since 
Rtn1Pho8*-GFP is a membrane protein, the AAA-type ATPase Cdc48, a molecular 
motor implicated in the removal of ERAD substrates from the ER membrane (Ye et al., 
2001), was also tested. CDC48 is an essential gene therefore we employed the 
temperature sensitive cdc48-3 mutant allele. Already at semi-permissive temperature 
(30°C) the tunicamycin induced degradation of galactose-driven Rtn1Pho8*-GFP was 
impaired in cdc48-3 cells, indicating that it is involved in the removal of the reporter 
from the ER membrane (Figure 9B). 
 
Figure 9. Rad6 and Cdc48 is required for Rtn1Pho8*-GFP degradation 
A) Mean GFP fluorescence, measured by flow cytometry, after tunicamycin treatment of wild-type 
(WT), ubr1∆, rad6∆, ubr2∆, san1∆ and ubr1∆ san1∆ cells expressing Rtn1Pho8*-GFP. Mean ± SEM, 
n = 3. B) Total GFP fluorescence, measured by flow cytometry, after promoter shut-off and 
tunicamycin treatment of WT and cdc48-3 cells expressing GAL1-driven Rtn1Pho8*-GFP. 
Mean ± SEM, n = 3. Experiment performed by Sebastian Schuck. 
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2.3 Regulation of SHRED 
2.3.1 The environmental stress response pathway is the main regulator of 
SHRED 
Thus far it has been elucidated that Ubr1, Ynm3 and Roq1 with the help of Rad6 and 
Cdc48 act in a linear pathway to degrade the misfolded ER reporter Rtn1Pho8*-GFP 
by the proteasome during ER-stress. The next major question was how the pathway is 
regulated. Tunicamycin inhibits glycosylation of luminal ER proteins or ER membrane 
proteins with luminal domains, however the reporter does not have any domain that is 
detectable from the luminal side nor is it glycosylated. This suggested that the effect of 
tunicamycin treatment on reporter degradation is indirect. Therefore, we tested if UPR 
signalling is required for SHRED. Deletion of UPR sensor IRE1 or UPR transcription 
factor HAC1, had no effect on the degradation of Rtn1Pho8*-GFP, ruling out UPR as 
a signalling pathway to regulate SHRED (Figure 10A). Persistent ER-stress is known 
to activate the general or environmental stress response (ESR) (Gasch et al., 2000). 
ESR initiates a broad remodelling of the proteome including downregulation of general 
protein synthesis and upregulation of chaperones and quality control factors during a 
wide variety of stresses (Gasch, 2003). During ideal growth conditions, protein kinase 
A (PKA), the main regulator of ESR, phosphorylates the transcription factors Msn2/4 
and Hsf1, thereby blocking their nuclear entry and thus their regulation of transcription 
(Görner et al., 1998). To test if ESR regulates SHRED we employed analogue sensitive 
mutants of the yeast PKA homologues TPK1/2/3. The mutations enlarge the ATP 
binding pocket (Hao and O’Shea, 2012), thus addition of a bulky ATP analogue 1-
NMPP-1 outcompetes cellular ATP and pharmacologically inhibits PKA (Bishop et al., 
2000). Activation of ESR in tpk1/2/3 cells via 1-NMPP-1 treatment led to the 
degradation of Rtn1Pho8*-GFP, which was dependent on SHRED (Figure 10B). 
Hence, SHRED and as a consequence RtnPho8*-GFP degradation can be induced in 
the absence of any ER stressor via pharmacological inhibition of PKA.  
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Figure 10. The environmental stress response pathway regulates SHRED 
A) Mean GFP fluorescence, measured by flow cytometry, after tunicamycin treatment of wild-type 
(WT), ire1∆ and hac1∆ cells expressing Rtn1Pho8*-GFP. Mean ± SEM, n = 3. B) Mean GFP 
fluorescence, measured by flow cytometry, after 1-NMPP-1 treatment of tpk1/2/3-as (WT), tpk1/2/3-
as ubr1∆ (ubr1∆), tpk1/2/3-as ynm3∆ (ynm3∆) and tpk1/2/3-as roq1∆ (roq1∆) cells expressing 
Rtn1Pho8*-GFP. Mean ± SEM, n = 3. Experiment performed by Sebastian Schuck. 
 
Since ESR is activated by many stressors (Gasch, 2003) we tested which other 
conditions could initiate degradation of Rtn1Pho8*-GFP. Treatment with rapamycin, an 
inhibitor of the main regulator of cell growth TOR1 (Loewith and Hall, 2011), also led 
to SHRED-dependent Rtn1Pho8*-GFP degradation (Figure 11A). Furthermore, 
Rtn1Pho8*-GFP was degraded in a SHRED-dependent manner when cells were 
grown for 24 hours in liquid culture so that they enter post-diauxic phase (Figure 11B). 
Thus, starvation conditions induced by rapamycin treatment or growth into post-diauxic 
phase, also initiate Rtn1Pho8*-GFP degradation. Hence, ESR emerged as the main 
regulator of SHRED raising the question which SHRED gene could be the main 
transcriptional target during stress.  
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Figure 11. Growth into post-diauxic phase initiates Rtn1Pho8*-GFP degradation 
A) Mean GFP fluorescence, measured by flow cytometry, after rapamycin treatment of wild-type (WT), 
ubr1∆, ynm3∆ and roq1∆ cells expressing Rtn1Pho8*-GFP. n = 1. B) Western blot of GFP and Pgk1 
from WT, ubr1∆, ynm3∆ and roq1∆ cells expressing Rtn1Pho8*-GFP in mid-log phase and in post-
diauxic phase. Pgk1 served as loading control. 
 
2.3.2 Regulation of ROQ1 expression is the initial step in SHRED  
The mRNA or protein levels of UBR1 or YNM3 do not increase during ER-stress 
(Pincus et al., 2014; Travers et al., 2000). However, ROQ1 expression is upregulated 
during a wide variety of stresses (Gasch et al., 2000). Indeed, qPCR data obtained by 
Rolf Schmidt showed that mRNA levels of ROQ1 increased at least 10-fold after 
tunicamycin treatment or during activation of ESR via 1-NMPP-1 treatment 
(Figure 12A). This result suggests that the initial step in SHRED is the transcriptional 
upregulation of ROQ1. If so, then overexpression of ROQ1 alone should be able to 
initiate SHRED. To test this idea an inducible expression system was employed 
(Pincus et al., 2014). Briefly, the endogenous promoter of ROQ1 was replaced by a 
GAL1 promoter. Additionally, an artificial transcription factor containing the Gal4 DNA 
binding domain, the Msn2 trans-activating domain and an estrogen receptor domain 
(abbreviated as GEM), was co-expressed in cells harbouring Rtn1Pho8*-GFP. 
Addition of β-estradiol induces a conformational change in GEM that enables its 
binding to and activation of GAL1-driven genes (Figure 12B). Overexpression of 
ROQ1 via the GEM system initiated Rtn1Pho8*-GFP degradation which was strictly 
dependent on UBR1 and YNM3 (Figure 12C). Importantly, overproduction of ROQ1 
did not affect the levels of the Rtn1-GFP control (Figure 12D) and did not cause any 
growth defect ruling out that overexpression of ROQ1 may cause stress that indirectly 
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upregulates SHRED (Figure 12E). Thus, ROQ1 overexpression alone initiated 
SHRED-dependent Rtn1Pho8*-GFP degradation. It is noteworthy that ROQ1 
overexpression induced a slower degradation phenotype compared to the 
tunicamycin-induced reporter degradation. Potentially tunicamycin treatment initiates 
other secondary effects, besides upregulating ROQ1 expression, that speed up the 
degradation of the reporter (see Discussion).  
 
Figure 12. ROQ1 overexpression initiates SHRED (legend on the following page) 
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Figure 12. ROQ1 overexpression initiates SHRED 
A) Normalized ROQ1 mRNA levels, determined by qPCR, after tunicamycin or 1-NMPP-1 treatment 
of wild-type (WT) and tpk1/2/3-as cells. Values were normalized to the mRNA levels of the TEF10 
housekeeping gene. Mean ± SEM, n = 3. Experiment performed by Rolf Schmidt. B) Schematic 
illustration of the GEM expression system (Pincus et al., 2014). C) Mean GFP fluorescence, 
measured by flow cytometry, after estradiol treatment of WT, ubr1∆ and ynm3∆ cells expressing 
Rtn1Pho8*-GFP, the GEM transcription factor and GAL1-driven endogenous ROQ1. Mean ± SEM, 
n = 3. D) Mean GFP fluorescence, measured by flow cytometry, after estradiol treatment of WT cells 
expressing Rtn1-GFP or Rtn1Pho8*-GFP, the GEM transcription factor and GAL1-driven endogenous 
ROQ1. Mean ± SEM, n = 4. Experiments in (C) and (D) were performed by Sebastian Schuck. E) 
Growth of WT cells expressing Rtn1Pho8*-GFP, the GEM transcription factor and Roq1 from the 
endogenous ROQ1 promoter or the GAL1 promoter, in SC media after estradiol treatment. Area under 
a 20-hour growth curve is plotted in arbitrary units. Mean ± SEM, n = 3. Experiment performed by 
Peter Bircham. 
 
2.4 Mechanism of SHRED 
2.4.1 Ynm3 cleaves Roq1 
After elucidating the initial step in SHRED, the role of YNM3 was investigated. The 
catalytically inactive Ynm3(S236A) (Padmanabhan et al., 2009) could not support the 
stress-induced degradation of Rtn1Pho8*-GFP (Figure 13A), indicating that cleavage 
of a substrate protein by Ynm3 is required for SHRED. Surprisingly, functional Ynm3-
GFP localized to the nucleus (Figure 13B, Belanger et al., 2009) and ER-stress did 
not initiate its relocalization to the cytosol (data not shown). Thus, it is unlikely that 
Ynm3 directly cleaves Rtn1Pho8*-GFP, which is localized at the peripheral ER. 
Instead, the relevant substrate might localize or has access to the nucleus. Roq1 is a 
soluble protein with a molecular weight of 12 kDa, which enables its passive diffusion 
through the nuclear pore complex. This encouraged us to test Roq1 as the proteolytic 
substrate of Ynm3. The endogenous Roq1 protein displays a very low abundance 
(Ghaemmaghami et al., 2003), therefore the C-terminally HA-tagged Roq1 was 
expressed from a strong GPD promoter. In wild-type cells, Roq1-HA appeared as a 15 
kDa protein (Figure 13C). Intriguingly, addition of proteasome inhibitor led to the 
detection of a second approximately 2 kDa smaller double band (Figure 13C arrows). 
Whether this double band represents post-translational modification has yet to be 
determined. Importantly, the smaller molecular weight band was absent in ynm3∆ cells 
indicating that it is a Ynm3-dependent cleavage fragment (Figure 13C). The cleavage 
fragment was only detectable after proteasome inhibition suggesting rapid turnover by 
the proteasome and low cleavage efficiency. It has been shown that the mammalian 
Ynm3 homologue Htra2 binds its substrates at the C-terminus (Walsh et al., 2003). 
Hence, the C-terminal HA-tag on Roq1 might interfere with the binding and cleavage 
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by Ynm3. Therefore, a Roq1 construct was generated with an internal HA-tag after the 
74th amino acid, termed Roq1-HA(74). This position was chosen because it is in a 
region of Roq1 that is particularly poorly conserved among yeast homologues. Both C-
terminally and internally HA-tagged Roq1 constructs were functional in Rtn1Pho8*-
GFP degradation (Figure 13D). Importantly, the Ynm3-dependent Roq1-HA(74) 
cleavage fragment was already detectable in the absence of proteasome inhibition 
(Figure 13E arrows).  
 
Figure 13. Ynm3 cleaves Roq1 (legend on the following page) 
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Figure 13. Ynm3 cleaves Roq1 
A) Mean GFP fluorescence, measured by flow cytometry, after tunicamycin treatment of ynm3∆ cells 
expressing Rtn1Pho8*-GFP. The cells additionally contained an empty plasmid or different versions 
of Ynm3 expressed from a plasmid. Mean ± SEM, n = 3. B) Fluorescent microscopy images of wild-
type cells expressing endogenously tagged Sec63-mCherry and plasmid-encoded (upper panel) or 
chromosomally GFP-tagged Ynm3 (lower panel). Scale bar: 2 µm. C) Western blot of HA and Pgk1  
from pdr5∆ (wild-type, WT) or pdr5∆ ynm3∆ (ynm3∆) cells expressing GPD-driven Roq1-HA after 
MG132 treatment where indicated. The double arrow indicates Roq1 cleavage fragments. Pgk1 
served as loading control. D) Mean GFP fluorescence, measured by flow cytometry, after tunicamycin 
treatment of roq1∆ cells expressing Rtn1Pho8*-GFP. The cells additionally contained an empty 
plasmid or different versions of Ynm3 expressed from a plasmid. Mean ± SEM, n = 3. E) Western blot 
of HA and Pgk1 from WT or ynm3∆ cells expressing GPD-driven Roq1-HA(74). The double arrow 
indicates Roq1 cleavage fragments. Pgk1 served as loading control. 
 
2.4.2 Cleaved Roq1 with a N-terminal arginine residue is required for SHRED 
The detection of the C-terminally HA-tagged Roq1 cleavage fragment indicates the 
cleavage to be located close to the N-terminus. Using the protein ladder as a reference 
for molecular weight we predicted the cleavage to occur approximately 20 amino acids 
(2 kDa) downstream from the N-terminus. To identify the cleavage site, a series of N-
terminal truncations were generated where the first 18 to 23 amino acids of Roq1 were 
removed. The small molecular size of these constructs allowed the comparison of their 
migration behaviour with the migration of the native Roq1 cleavage fragment on a Tris-
Tricine SDS-PAGE gel. To enable translation of the N-terminal truncation constructs, 
a ubiquitin moiety was fused directly N-terminus, yielding the constructs Ub-Roq1∆18-
HA(74) to Ub-Roq1∆23-HA(74). After translation ubiquitin is efficiently removed by 
cellular deubiquitinases, releasing the N-terminally truncated Roq1 constructs 
(Bachmair et al., 1986). Similar to the native cleavage fragment, the truncated 
constructs appeared as double bands. Roq1∆21 showed the most similar migration 
pattern to the native cleaved Roq1 indicating that Ynm3 cleaves Roq1 after leucine-21 
(Figure 14A).  
If the sole function of Ynm3 in SHRED is to cleave and activate Roq1, then 
overexpression of cleavage-mimicking Roq1∆21 fragment should bypass the 
requirement for Ynm3. Indeed, expression of Roq1∆21 in ynm3∆ roq1∆ cells restored 
the stress-induced degradation of Rtn1Pho8*-GFP (Figure 14B, dashed box). In 
contrast, expression of Roq1∆20 or Roq1∆22, the two closest fragments regarding 
their electrophoretic mobility, could not bypass the requirement for Ynm3 (Figure 14B). 
Surprisingly, expression of Roq1∆23 also restored the degradation of Rtn1Pho8*-GFP, 
despite its clearly distinctive migration behaviour on the Tris-Tricine gel (Figure 14A). 
Therefore, we extended the truncations from Roq1∆7 through Roq1∆25. Interestingly, 
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all truncated constructs that harboured a positively charged N-terminal residue (lysine 
or arginine) or amino acids that can be turned into these amino acids via deamidylation 
and arginylation (asparagine, aspartic acid, glutamine, glutamic acid) (Baker and 
Varshavsky, 1995; Balzi et al., 1990) were capable of bypassing the requirement for 
Ynm3 (Figure 14B). To confirm the requirement for a positively charged residue on 
the N-terminus of cleaved Roq1, we mutated arginine-22 in the Roq1∆21 construct. 
Mutating it to a neutral alanine or leucine residue abolished its function while mutating 
it to a positively charged lysine residue maintained its function in Rtn1Pho8*-GFP 
degradation (Figure 14C). Thus, a positively charged residue on the Roq1 cleavage 
fragment is required for SHRED.  
In order to confirm that Roq1 is cleaved after leucine-21 mutations were introduced at 
this position in full-length Roq1-HA(74). The mammalian Ynm3 homologue HtrA2/Omi 
preferentially cleaves after leucine, isoleucine or valine residue (Vande Walle et al., 
2007). In agreement with the latter finding mutating leucine-21 to a structurally similar 
valine residue had no effect on cleavage while the introduction of a proline mutation 
abolished cleavage (Figure 14D). Accordingly, full-length Roq1(L21P) could not 
restore Rtn1Pho8*-GFP degradation in roq1∆ cells while Roq1(L21V) was still 
functional (Figure 14E). Thus, Ynm3 cleaves Roq1 after leucine-21 and uncovers a 
positively charged arginine residue on the new N-terminus that is required for SHRED.  
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Figure 14. Roq1 is cleaved after leucine-21 
A) Western blot of HA from roq1∆ cells expressing full-length Roq1 (WT, wild-type) or ynm3∆ roq1∆ 
cells expressing N-terminally truncated Roq1 variants lacking the indicated number of N-terminal 
residues. The double arrow indicates Roq1 cleavage fragments. B) Mean GFP fluorescence, 
measured by flow cytometry, after five hours of tunicamycin treatment of ynm3∆ roq1∆ cells 
expressing Rtn1Pho8*-GFP and full-length or N-terminally truncated Roq1 variants lacking the 
indicated number of N-terminal residues. The letters above the numbers indicate the N-terminal 
residue in the Roq1 cleavage fragment. The red dashed box marks the Roq1 variants used in (A). 
Mean ± SEM, n = 3. C) Mean GFP fluorescence, measured by flow cytometry, after five hours of 
tunicamycin treatment of ynm3∆ roq1∆ cells expressing Rtn1Pho8*-GFP and full-length or N-
terminally truncated and mutated versions of Roq1. Mean ± SEM, n = 3. D) Western blot of HA and 
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Pgk1 from roq1∆ cells expressing GPD-driven wild-type (WT) or point mutant full-length Roq1-HA(74). 
The double arrow indicates Roq1 cleavage fragments. The asterisk denotes an alternative cleavage 
product. Pgk1 served as loading control. E) Mean GFP fluorescence, measured by flow cytometry, 
after five hours of tunicamycin treatment of roq1∆ cells expressing Rtn1Pho8*-GFP and full-length 
WT or mutated versions of Roq1 from a plasmid. Mean ± SEM, n = 3. 
 
2.4.3 Roq1 binds to and activates Ubr1 
through the type-1 site 
Next, we investigated the role of a positively 
charged N-terminal residue in cleaved Roq1. N-
terminal arginines and lysines are type-1 Ubr1 
substrates according to the N-end rule that 
determines the half-life of a protein based on its 
N-terminal residue (Tasaki et al., 2012; 
Varshavsky, 2011). Ubr1 harbours two mapped 
N-end rule substrate-binding sites: the type-1 
site binds to positively charged residues while 
the type-2 site recognizes bulky hydrophobic residues (Figure 15) (Xia et al., 2008). 
To test if any of these sites are required for Rtn1Pho8*-GFP degradation we created 
site mutant Ubr1 constructs. 
While, the type-2 site can be independently mutated, mutation in the type-1 site is 
known to affect the type-2 site as well (Tasaki et al., 2009; Xia et al., 2008). Thus, we 
first tested the functionality of the created Ubr1 site mutants. For this purpose, we 
employed the tandem fluorescent timer (tFT) tagged N-end rule reporter constructs 
developed in the Knop lab (Khmelinskii et al., 2012). The system is based on the fusion 
of a fast folding superfolder GFP (sfGFP) and a slower maturing mCherry (Pédelacq 
et al., 2006; Shaner et al., 2004). Therefore, the mCherry over sfGFP fluorescence 
intensity ratio indicates the average age of the tFT-tagged protein of interest 
(Khmelinskii et al., 2012). The N-end rule reporter constructs contained N-terminal 
ubiquitin fusions of all 20 proteinogenic amino acids with a tFT-tag, termed Ub-X-tFT 
(X stands for any proteinogenic residue). As expected, constructs with type-1 N-
terminal residues (E, K, Q, R, D, N) showed the lowest mCherry over sfGFP ratio 
indicating a short half-life (Figure 16A, red bars). On the other hand, constructs with 
neutral N-terminal amino acids (T, V, A, G, S, M, C) displayed higher fluorescent ratio, 
indicating longer half-life (Figure 16A, grey bars). The type-2 constructs presented 
somewhat longer half-lives than the type-1 constructs (Figure 16A, blue bars).  
Figure 15. The N-end rule pathway 
Schematic illustration of N-end rule 
substrate recognition by Ubr1.  
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In order to test the functionality of different Ubr1 site mutants Ub-R-tFT was selected 
as a type-1 and Ub-F-tFT as a type-2 model substrate. The stable non-N-end rule 
substrate Ub-M-tFT served as negative control. These selected N-end rule substrates 
were expressed in ubr1∆ cells in which different versions of Ubr1 were expressed from 
a plasmid. Expression of wild-type Ubr1 reduced the mCherry/sfGFP ratio in both the 
Ub-R-tFT and the Ub-F-tFT constructs indicating that they are turned over in a Ubr1-
dependent manner (Figure 16B). Since Ub-M-tFT is a stable construct (Figure 16A) 
expression of wild-type Ubr1 had no effect on its mCherry/sfGFP ratio (Figure 16B). 
As expected, the type-2 site mutant Ubr1(D318N) was unable to degrade Ub-F-tFT but 
could still process Ub-R-tFT. On the other hand, the type-1 mutant Ubr1(G173R) was 
unable to degrade Ub-R-tFT but retained partial activity towards Ub-F-tFT (Figure 
16B). Thus, in our hands the type-2 site could be mutated independently while mutation 
to the type-1 site had an effect on type-2 substrates as well.  
Using these Ubr1 site mutants, we tested which Ubr1 substrate-binding site is required 
for Rtn1Pho8*-GFP degradation. The type-2 mutant Ubr1(D318N) could restore 
degradation of Rtn1Pho8*-GFP in ubr1∆ cells comparably to wild-type Ubr1 while type-
1 mutant Ubr1(G173R) could not (Figure 16C). Hence, the Ubr1 type-1 substrate-
binding site is required for SHRED.  
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Figure 16. The type-1 substrate-binding site of Ubr1 is required for Rtn1Pho8*-GFP 
degradation 
A) mCherry over sfGFP fluorescence intensity ratio, measured by flow cytometry, from wild-type cells 
expressing Ubiquitin-X-mCherry-sfGFP (X stands for any proteinogenic amino acid). The letters 
below each bar indicates the N-terminal residue in the X position after the removal of ubiquitin. Grey 
bars indicate neutral amino acids, while red and blue bars indicate type-1 or type-2 amino acids, 
respectively. B) mCherry over sfGFP fluorescent intensity ratio, measured by flow cytometry, from 
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ubr1∆ cells expressing M, R or F-mCherry-sfGFP. The cells additionally contained an empty plasmid 
or different versions of Ubr1 expressed from a plasmid. C) Mean GFP fluorescence, measured by 
flow cytometry, after tunicamycin treatment of ubr1∆ cells expressing Rtn1Pho8*-GFP. The cells 
additionally contained the plasmids used in (B).  
 
It is unlikely that Rtn1Pho8*-GFP is directly recognised by Ubr1 through the type-1 site, 
since it does not harbour a type-1 destabilizing residue on the N-terminus (starts with 
a methionine-serine). Moreover, the stability of Rtn1-GFP, but not of Rtn1Pho8*-GFP, 
during ER-stress (Figure 4B) implies the degron to be localized in the internal Pho8* 
domain. Besides binding to N-end rule substrates Ubr1 also binds at least one 
additional substrate through a third internal binding site that is unmapped (Du et al., 
2002). Normally an auto-inhibitory domain of Ubr1 blocks the third binding site. 
However, simultaneous occupancy of the type-1 and type-2 site relieves the inhibition 
and allows the binding to and degradation of target proteins through the third site (Du 
et al., 2002). The C-terminal Roq1 cleavage fragment harbours a type-1 arginine N-
end rule residue. We therefore hypothesized that the positively charged N-terminus of 
cleaved Roq1 interacts with and regulates Ubr1 through the type-1 site to promote 
recognition of misfolded proteins.  
In order to test this hypothesis, we performed co-immunoprecipitation experiments 
between chromosomally integrated Roq1∆21 variants and plasmid-borne Ubr1 
constructs. Immunoprecipitated Roq1∆21-HA(74) interacted with FLAG-Ubr1 
dependent on the N-terminal arginine of cleaved Roq1 (Figure 17A). Importantly type-
1 site mutant Ubr1(G173R) could not interact with Roq1∆21-HA(74) (Figure 17A), 
indicating that cleaved Roq1 binds to the Ubr1 type-1 site through its N-terminal 
arginine. 
This model suggests that the Roq1 cleavage fragment would compete with type-1 N-
end rule substrates for the type-1 binding site. To test this, we made use of the tFT-
tagged N-end rule substrates. Overexpression of full-length Roq1 led to the 
stabilization of type-1 and destabilization of type-2 substrates, which was strictly 
dependent on YNM3 and UBR1 (Figure 17B). This result shows that cleaved Roq1 
outcompetes the type-1 substrates at the type-1 binding site. Accordingly, Roq1 
overexpression decreased the amount of R-tFT bound to Ubr1 determined by co-
immunoprecipitation (Figure 17C). Moreover, Roq1 binding enhanced degradation of 
type-2 substrates suggesting that the binding activates Ubr1 to degrade substrate 
proteins more efficiently (Figure 17B). Accelerated degradation of type-2 substrates 
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upon occupancy of the type-1 site agrees with the previous findings (Baker and 
Varshavsky, 1991). Thus, cleaved Roq1 binds to Ubr1 through the type-1 site and 
changes its substrate specificity leading to decreased degradation of type-1 substrates 
and enhanced degradation of type-2 substrates and Rtn1Pho8*-GFP.  
 
Figure 17. Cleaved Roq1 binds to and activates Ubr1 (legend on the following page) 
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Figure 17. Cleaved Roq1 binds to and activates Ubr1 
A) Western blot of FLAG and HA from cell lysates or anti-HA immunoprecipitates from roq1∆ ubr1∆ 
cells. The cells additionally expressed wild-type or R22A mutant Roq1∆21-HA(74) from the 
chromosome and wild-type FLAG-Ubr1 or type-1 site mutant FLAG-ubr1(G173R) from a plasmid 
where indicated. B) mCherry over sfGFP fluorescence, measured by flow cytometry, from wild-type 
(WT), ynm3∆ and ubr1∆ cells expressing Ubiquitin-X-mCherry-sfGFP (X stands for any proteinogenic 
amino acid). The cells additionally expressed the GEM transcription factor and GAL1-driven 
chromosomal Roq1. Plotted on a log2 scale is the fold change of mCherry/sfGFP fluorescence 
intensity upon 6 hours of estradiol treatment. The letters below each bar indicate the N-terminal 
residue in position X after the removal of ubiquitin. Values above 0 indicate stabilization and longer 
half-life, while values below zero correspond to de-stabilization and shorter-half-life. Mean, n = 2. C) 
Western blot and quantification of FLAG, mCherry and HA from cell lysates or anti-FLAG 
immunoprecipitates from roq1∆ ubr1∆ cells. The cells additionally expressed Roq1∆21-HA(74) and 
Ub-R-mCherry-sfGFP from the chromosome and RING mutant FLAG-ubr1(C1220S) from a plasmid 
where indicated. This Ubr1 mutation was used to stabilize the interaction between Ubr1 and R-
mCherry-sfGFP. Quantification shows the ratio of mCherry signal to the corresponding FLAG signal. 
Mean ± SEM, n = 3. 
 
2.4.4 Roq1 is a short-lived protein 
Finally, we wanted to address the shutdown mechanism of the SHRED pathway. 
Cycloheximide chase experiments revealed that both full-length and cleaved Roq1 are 
very short lived (Figure 18A, B). Thus, the short half-life of the Roq1 protein allows 
tight regulation of SHRED by rapid turnover of Roq1 protein once expression comes 
to a halt. Interestingly, UBR1 deletion had only a minor effect on the steady-state levels 
of Roq1 (Figure 18A), suggesting that the major ubiquitin E3 ligase involved in the 
turnover of Roq1 is not Ubr1. In conclusion, the mechanistic analyses have revealed 
that different stressors can transcriptionally upregulate ROQ1 expression and the 
resulting Roq1 protein is subsequently cleaved by Ynm3. Cleaved Roq1 then exposes 
an N-terminal arginine and by this binds to and regulates Ubr1 substrate specificity.  
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Figure 18. Roq1 is an unstable protein 
A) Western blot of HA and Pgk1 from pdr5∆ (wild-type) or ubr1∆ cells expressing GPD-driven Roq1-
HA(74) after cycloheximide (CHX) and MG132 treatment where indicated. Marked with arrows are 
the full-length and cleaved Roq1. Pgk1 served as loading control. B) Mean HA levels of cleaved Roq1 
from (A) relative to Pgk1 and normalized to 0h time point.  
 
2.5 Substrates of SHRED 
2.5.1 SHRED degrades misfolded cytosolic and ER membrane proteins 
Next, we investigated the substrate spectrum of SHRED by testing different misfolded 
model proteins. First, the degradation phenotype of Yop1Pho8*-GFP and Rtn1CPY*-
GFP was compared to Rtn1Pho8*-GFP. Changing the ER anchor to another reticulon 
protein Yop1 resulted in a stable protein (Figure 19A) but ER-stress induced its 
degradation, which was dependent on SHRED (Figure 19B). As shown before (Figure 
3A, B), Rtn1CPY*-GFP was continuously degraded and genetic analysis revealed that 
Hrd1, Doa10 and Ubr1 are required for its steady-state turnover (Figure 19C). 
Importantly, tunicamycin treatment enhanced its degradation, which was dependent 
on SHRED (Figure 19B). This result suggests that under normal growth conditions 
Rtn1CPY*-GFP is a canonical ERAD and Ubr1 substrate, however, during ER-stress 
its degradation is accelerated through SHRED. Next we tested cystic fibrosis 
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transmembrane conductance regulator (CFTR), a well-studied polytopic ERAD and 
Ubr1 substrate under standard growth conditions (Stolz et al., 2013). Since ER-stress 
is known to upregulate ERAD components (Travers et al., 2000), we analysed the 
stress-induced degradation of CFTR in ERAD-deficient hrd1∆ doa10∆ cells. As for the 
Rtn1-based reporters, tunicamycin induced SHRED-dependent degradation of CFTR 
(Figure 19D).  
 
Figure 19. SHRED degrades misfolded ER membrane proteins 
A) Total GFP fluorescence, measured by flow cytometry, after cycloheximide treatment of wild-type 
cells expressing Rtn1-GFP, Hmg2-GFP, Rtn1Pho8*-GFP or Yop1Pho8*-GFP. Mean ± SEM, n = 3. 
B) Mean GFP fluorescence, measured by flow cytometry, after five hours of tunicamycin treatment of 
wild-type (WT), ubr1∆, ynm3∆ and roq1∆ cells expressing Rtn1Pho8*-GFP, Yop1Pho8*-GFP or 
Rtn1CPY*-GFP. Mean ± SEM, n = 3. C) Total GFP fluorescence, measured by flow cytometry, after 
cycloheximide treatment of WT, ubr1∆, ynm3∆, roq1∆ and hrd1∆ doa10∆ cells expressing Rtn1CPY*-
GFP. Mean ± SEM, n = 3. D) Western blot of HA and Pgk1 from hrd1∆ doa10∆, hrd1∆ doa10∆ ubr1∆, 
hrd1∆ doa10∆ ynm3∆ and hrd1∆ doa10∆ roq1∆ cells expressing CFTR-HA after tunicamycin (Tm) 
treatment. Numbers under the blots indicate the mean ± SEM HA signal relative to Pgk1 and 
normalized to 0h time point. Pgk1 served as loading control. 
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Since all SHRED components are soluble proteins we investigated if the pathway is 
also responsible for the degradation of cytosolic misfolded proteins. First, degradation 
of a mutant and misfolded version of firefly luciferase, LuciferaseDM-mCherry was 
investigated (Gupta et al., 2011). Compared to wild-type Luciferase-mCherry the 
mutant version was degraded faster (Figure 20A) and tunicamycin treatment further 
enhanced its degradation in a SHRED-dependent manner (Figure 20B). UBR1 
deletion showed the strongest effect suggesting a role for Ubr1 acting parallel to 
SHRED during stress. Importantly, overexpression of ROQ1 via the GEM expression 
system induced LuciferaseDM-mCherry but not wild-type Luciferase-mCherry 
degradation (Figure 20C). This is consistent with degradation phenotype of 
Rtn1Pho8*-GFP, but not of Rtn1-GFP, upon ROQ1 overexpression (Figure 12D). 
Additionally, the truncated, misfolded and therefore continuously degraded mutant 
protein stGnd1 (Heck et al., 2010) also degraded upon ER-stress dependent on 
SHRED (Figure 20D). Hence, SHRED emerged as a stress-activated quality control 
pathway that degrades both misfolded cytosolic and ER membrane proteins.  
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Figure 20. SHRED mediates the degradation of cytoplasmic misfolded proteins 
A) Western blot of mCherry and Pgk1 from wild-type cells expressing wild-type Luciferase-mCherry 
or point mutant Luciferase(DM)-mCherry after cycloheximide (CHX) treatment. Pgk1 served as 
loading control. Experiment performed by Juan Diaz-Miyar. B) Mean mCherry fluorescence, 
measured by flow cytometry, after tunicamycin treatment of wild-type (WT), ubr1∆, ynm3∆ and roq1∆ 
cells expressing Luciferase(DM)-mCherry. Mean ± SEM, n = 3. C) Mean mCherry fluorescence, 
measured by flow cytometry, after estradiol treatment of WT cells expressing the GEM transcription 
factor, GAL1-driven endogenous Roq1 and Luciferase-mCherry or Luciferase(DM)-mCherry. Mean ± 
SEM, n = 4. Experiment performed by Sebastian Schuck. D) Mean mCherry fluorescence, measured 
by flow cytometry, after tunicamycin treatment of WT, ubr1∆, ynm3∆ and roq1∆ cells expressing 
stGnd1-mCherry. Mean ± SEM, n = 3. 
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2.5.2 Genetic screening to uncover endogenous SHRED substrates 
Is SHRED only responsible for degrading misfolded proteins for quality control 
purposes or does it adjust the levels of well-folded endogenous proteins for regulatory 
purposes as well? To uncover possible endogenous substrates of SHRED we 
performed two different genetic screens. In the first approach the tFT-tag genetic library 
was employed (Khmelinskii et al., 2014). The library contains approximately 70% of all 
yeast ORFs with a C-terminal tFT-tag. We introduced a ROQ1 or URA3 (wild-type 
control) deletion into the tFT library through mating and sequential selection steps (see 
Methods for the synthetic genetic array). After the final selection the mCherry and 
sfGFP fluorescence intensity was measured in haploid colonies after 24 hours of 
growth on plates using a fluorescence plate reader (Figure 21A). On each screening 
plate, Rtn1-tFT and Rtn1Pho8*-tFT served as negative and positive control, 
respectively. Growing cells on agar plates (colonies) resulted in a similar Rtn1Pho8*-
GFP degradation phenotype as growing cells in liquid culture into stationary phase 
(Figure 11C). Therefore, as expected, Rtn1-tFT showed a nearly identical 
mCherry/sfGFP fluorescence ratio in ura3∆ and roq1∆ cells indicating similar turnover 
in both strains. In contrast, Rtn1Pho8*-tFT showed a higher fluorescence ratio in the 
roq1∆ strain compared to ura3∆ indicating a slower turnover (data not shown). 
Candidate SHRED substrates were selected based on the fluorescence ratio 
difference between roq1∆ and ura3∆ cells (see Materials and Methods for filtering 
details). Filtering of the hits resulted in a list of approximately 250 potential substrates 
for SHRED. In order to validate these candidate substrates, we re-screened 152 of 
those potential substrates in liquid culture measuring the fluorescence with the flow 
cytometer. Fluorescence intensities of the candidate substrates were measured in 
logarithmic growth phase and after 24 hours of growth when cells reached post-diauxic 
phase. As expected, Rtn1-tFT did not show any difference in mCherry/sfGFP ratio 
between ura3∆ and roq1∆ strains during both mid-log phase and post-diauxic phase 
(Figure 21B, C). On the other hand, Rtn1Pho8*-tFT displayed the same 
mCherry/sfGFP ratio in both strain backgrounds during log phase but the 
mCherry/sfGFP ratio increased after 24 hours of growth in the roq1∆ strain (Figure 
21B, C). Of all the 152 re-screened hits only Cam1-tFT, Tef4-tFT, Sfa1-tFT and Glo1-
tFT presented a similar phenotype as Rtn1Pho8*-tFT, meaning identical 
mCherry/sfGFP ratio in mid-log phase but higher ratio in roq1∆ cells compared to ura3∆ 
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after 24 hours of growth (Figure 21B, C). The rest of the candidate hits were either not 
detectable by flow cytometry or did not confirm the phenotype seen in the plate-based 
screen.  
In order to validate the candidate hits as SHRED substrates, we tagged Cam1 and 
Tef4, the two most prominent hits, endogenously with an HA-tag and followed their 
protein levels in liquid culture by western blot. We used the small HA-tag to rule out 
the possibility that the large size of the tFT-tag (52 kDa) perturbs the native folding 
function of the protein. In agreement with the results from the tFT screen, both Cam1-
HA and Tef4-HA protein levels dropped in a SHRED-dependent manner after growing 
the cells into post-diauxic phase (Figure 21D, E). Hence, the tFT screen offered us 
candidate hits, whose protein levels are regulated by SHRED during post-diauxic 
phase.  
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Figure 21. Candidate SHRED substrates discovered via a genetic screen 
A) Schematic illustration of the screening strategy to discover endogenous SHRED substrates using 
the tFT-tag genetic library. Screen was performed jointly with Juan Diaz-Miyar. B) mCherry over 
sfGFP fluorescence intensity ratio, measured by flow cytometry, from wild-type (WT) and roq1∆ cells 
in mid-log phase expressing Rtn1-tFT, Rtn1Pho8*-tFT, Cam1-tFT, Tef4-tFT, Sfa1-tFT and Glo1-tFT. 
Mean ± SEM, n = 3. C) as in (B) but cells were grown for 24 hours into post-diauxic phase. Mean ± 
SEM, n = 3. D) Western blot of HA and Pgk1 from WT, ubr1∆, ynm3∆ and roq1∆ cells expressing 
endogenously tagged Cam1-HA in logarithmic growth phase or in post-diauxic phase. The numbers 
below the blots are fold change of the mean HA signal, relative to Pgk1, normalized to the HA signal 
in WT cells. E) As in (D) but cells expressed endogenously tagged Tef4-HA.  
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2.5.3 Search for endogenous SHRED substrates via mass spectrometry 
In the second screening approach for endogenous substrates we exploited the fact 
that overexpression of Roq1 alone activates SHRED and Rtn1Pho8*-GFP degradation 
(Figure 12C, D). In collaboration with Georg Borner (MPI for Biochemistry, 
Martinsried), we compared the proteome of wild-type and ubr1∆ strains after eight 
hours of Roq1 overexpression using the GEM expression system. For control purposes 
both strains harboured the Rtn1Pho8*-GFP reporter whose levels dropped by 
approximately 35% in wild-type but not in ubr1∆ cells upon Roq1 overexpression (data 
not shown). After a series of filtering and statistical analysis, we compiled a list of 
18 candidate SHRED substrates, with a false discovery rate of 20%, whose protein 
levels reduced at least 25% in wild-type but not in ubr1∆ cells (Figure 22A, third 
column). Four of the candidate substrates (Caf20, Mmm1, Ncs6, Srp14) showed 
similar steady-state levels in wild-type and ubr1∆ cells (Figure 22A, fourth column) 
reproducing the phenotype of Rtn1Pho8*-GFP. The candidate proteins were either 
soluble (cytosolic or nuclear) or membrane proteins of the ER, Golgi complex or the 
mitochondria, suggesting that SHRED could be responsible for the degradation of a 
wide variety of endogenous proteins from different subcellular compartments.  
In contrast to Rtn1Pho8*-GFP, the protein levels of Aap2, Yfr006w, Eaf5 and Agc1 
were already reduced in ubr1∆ cells steady-state (Figure 22A, fourth column). This 
suggests that Ubr1 degrades them when SHRED is active, however when SHRED is 
inactive Ubr1 indirectly upregulates them. Further analysis on low abundant proteins 
revealed that Ptr2 strongly represents this phenotype: Ptr2 protein levels are reduced 
upon Roq1 overexpression and UBR1 deletion (Figure 22B, left and centre panel), 
but unaffected by the overexpression of Roq1 in ubr1∆ cells (Figure 22B, right panel). 
Ptr2 is a plasma membrane di- and tripeptide transporter (Perry et al., 1994), whose 
expression is negatively regulated by a transcriptional repressor Cup9, which itself is 
degraded by Ubr1 upon its allosteric activation by dipeptides (Turner et al., 2000). 
Therefore, in the absence of Ubr1 high levels of Cup9 repress PTR2 transcription 
leading to low Ptr2 protein levels.  
In wild-type cells, overexpression of Roq1 resulted in a drop of Ptr2 protein levels 
(Figure 22B, left panel), suggesting that the excessive amount of Roq1 perturbed 
Ubr1-mediated degradation of Cup9 and thus it repressed PTR2 expression. Indeed, 
qPCR data confirmed that Roq1 overexpression decreased PTR2 mRNA levels in wild-
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type cells but had no effect on the already low PTR2 mRNA levels in ubr1∆ cells 
(Figure 22C). This result suggests that Roq1, through the activation of SHRED, 
reprograms Ubr1 to degrade misfolded and native proteins and at the same time 
inhibits the degradation of Cup9. Hence, both screening approaches offered candidate 
endogenous substrates for SHRED. 
 
Figure 22. Candidate SHRED substrates discovered by mass spectrometry 
A) Table of candidate SHRED substrates whose protein levels dropped at least by 25% upon Roq1 
overexpression with a maximum false discovery rate (FDR) of 20%. Data analysis performed by 
Daniel Itzhak and Georg Borner. B) The effect of Roq1 overexpression and UBR1 deletion on protein 
levels. The X-axis shows the average fold change of expression between two strains; the Y-axis 
shows the result of a t-test for that difference (two-tailed, n = 4). The ‘volcano’ lines indicate thresholds 
of significance (FDR = 5%). Data analysis performed by Daniel Itzhak and Georg Borner. C) PTR2 
mRNA levels, determined by qPCR, of wild-type (WT) and ubr1∆ cells after Roq1 overexpression 
where indicated. Values were normalized to the mRNA levels of the TEF10 housekeeping gene. 
Mean ± SEM, n = 3. 
 ________________________________________  DISCUSSION 
51 
 
DISCUSSION 
Deteriorating protein quality during stress conditions is an intensively investigated field 
of molecular biology and biochemistry (Labbadia and Morimoto, 2015). In this PhD 
thesis, we have uncovered a novel stress-regulated protein quality control pathway 
that selectively recognizes and degrades misfolded as well as native ER membrane 
and cytosolic proteins. We named this pathway SHRED for Stress-induced 
Homeostatically Regulated Degradation. Using yeast genetics and various molecular 
biology and biochemical assays, we have elucidated how these proteins act in a linear 
degradation pathway. Specifically, various stressors transcriptionally upregulate the 
ROQ1 gene. Subsequently the resulting Roq1 protein is cleaved by Ynm3. Cleaving 
Roq1 exposes an N-terminal arginine and through this modulates the substrate 
specificity of the E3 ligase Ubr1 (Figure 23). Altered substrate specificity of Ubr1 leads 
to enhanced proteasomal degradation of SHRED substrates. Furthermore, a genetic 
screen and mass spectrometry analysis revealed endogenous candidate substrates of 
SHRED.  
 
Figure 23. Mechanistic model of SHRED 
Stress upregulates ROQ1 expression and the resulting Roq1 protein is cleaved by the serine protease 
Ynm3 between leucine-21 and arginine-22. Cleaved Roq1, with an N-terminal arginine residue, directly 
interacts with Ubr1 and modulates its substrate specificity. Rapid degradation of cleaved Roq1 by the 
proteasome enables swift downregulation of the pathway as soon as stress subsides. 
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3.1 Transcriptional regulation of SHRED via Roq1 
The initial and key step in SHRED is the transcriptional upregulation of the ROQ1 gene. 
Our results confirmed the previous finding (Pincus et al., 2014; Travers et al., 2000) 
that ER-stress upregulates ROQ1 transcription. However, ROQ1 transcription is also 
upregulated during a wide variety of other stressors including heat shock (Gasch et al., 
2000) osmotic shock (O’Rourke and Herskowitz, 2004), oxidative stress (Guan et al., 
2012) and nitrogen starvation (Gasch et al., 2000). Moreover, overexpression of ERAD 
and SHRED substrate CFTR (Buck et al., 2015) or non-translocated and potentially 
unfolded secretory proteins also upregulate ROQ1 transcription (Mutka and Walter, 
2001). Thus, multiple signals converge on and stimulate ROQ1 transcription. Besides 
activating their own response pathway, all these stressors trigger the environmental 
stress response (ESR) through PKA signalling (Gasch, 2003). In accordance with this, 
the ROQ1 promoter contains a stress response element (AGGGG) that is bound by 
the ESR transcription factors Msn2/4. Indeed, deletion of MSN2/4 abrogated reporter 
degradation (data not shown), confirming their importance in the regulation of ROQ1 
transcription. However, the ROQ1 promoter contains a binding site for the heat shock 
factor Hsf1 as well (Yamamoto et al., 2005). HSF1 is activated by many stressors and 
is also regulated by ESR via PKA (Vihervaara and Sistonen, 2014). Thus, the 
transcriptional regulation of ROQ1/SHRED is likely not controlled by a single 
transcription factor but rather by a network of regulatory proteins.  
 
3.2 The proteolytic cleavage site within Roq1 
After transcriptional upregulation of the ROQ1 gene the resulting Roq1 protein is 
cleaved by the serine protease Ynm3 between leucine-21 and arginine-22. Ynm3 
belongs to the High temperature requirement A (HtrA) serine protease family whose 
members are trypsin-type proteases based on their catalytic triad (Clausen et al., 
2002). The bacterial homologues DegP/Q and the mammalian counterpart HtrA2 
preferentially cleave after aliphatic valine, isoleucine, methionine or leucine residues 
(Martins et al., 2003; Vande Walle et al., 2007). Thus, the identified cleavage site within 
Roq1 fits the cleavage site preference of HtrA family members.  
Only one Ynm3 substrate is published, the inhibitor-of-apoptosis (IAP) protein Bir1 
(Walter et al., 2006; Zhang et al., 2017). Bir1 is the sole known IAP protein in budding 
 ________________________________________  DISCUSSION 
53 
 
yeast, therefore deletion of BIR1 leads to increased apoptotic cell death (Walter et al., 
2006). The cleavage site within Bir1 is not determined, thus a direct comparison of the 
two proteolytic sites is not possible. However, it raises the question how Ynm3 
distinguishes between its two proteolytic substrates Roq1 and Bir1. Similar to Roq1, 
Bir1 is a very lowly abundant protein (Ghaemmaghami et al., 2003). However, in 
contrast to ROQ1 transcriptional regulation, BIR1 transcription is essentially not 
modulated by stressors (Causton et al., 2001; Gasch et al., 2000). Thus, we believe 
that Roq1 is the main proteolytic target of Ynm3 during stress conditions. 
 
3.3 Substrate recognition by Ynm3 
In order to cleave their substrates, proteases have to specifically recognise and bind 
to their proteolytic substrates. Where does Ynm3 interact with Roq1 to subsequently 
mediate the cleavage? Tagging Roq1 on the C-terminus rendered the protein partially 
non-functional and cleavage was less efficient. This observation suggests that Ynm3 
might bind Roq1 at or close to the C-terminus. Accordingly, the Ynm3 bacterial 
homologue DegS binds to its proteolytic substrates at their very C-terminus (Walsh et 
al., 2003). Intriguingly, the Ynm3 bacterial homologue DegP is a member of the family 
of “ruler” proteases (Krojer et al., 2008a). In these enzymes the physical distance 
between the substrate-binding domain and the proteolytic active site acts as a 
molecular ruler to establish the cleavage site within the substrate protein. Thus, 
hypothetically the Ynm3 binding site on Roq1 might also influence the location of the 
cleavage site. Or vice versa, since we discovered the cleavage site within Roq1, the 
Ynm3 binding site could be determined from the proteolytic site.  
How does Ynm3 bind to its substrates? The defining features of HtrA proteases are a 
single trypsin-like protease domain and one or two protein-protein interacting PDZ 
domains (Clausen et al., 2002). The bacterial homologues DegS/P were shown to bind 
their substrates via the PDZ domains (Merdanovic et al., 2010). Conversely, the 
mammalian homologue HtrA1 binds its substrate directly by the protease domain 
(Truebestein et al., 2011). In contrast to the default domain architecture of HtrA family 
members, Ynm3 and several other plant or algae homologues, contain two protease 
domains (a proteolytically active and an inactive one) and four PDZ domains 
(Schuhmann et al., 2011). This was likely the result of a gene duplication and fusion 
event from an original DegP-like HtrA protease (Schuhmann et al., 2011). A recent in 
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vitro cryo-electron microscopy (EM) study on the structure of Ynm3 suggests that the 
first PDZ domain is available for substrate binding, while the conformation of the other 
three PDZ domains are blocked from substrate engaging (Zhang et al., 2017). 
Therefore, the first PDZ domain is a good candidate for a role in substrate binding. 
Additionally, deletion of PDZ1 and 2 in vivo rendered Ynm3 unstable, indicating an 
important role for these PDZ domains in the stability of the entire protein as well 
(Padmanabhan et al., 2009).  
Another intriguing aspect that could influence substrate binding is the oligomerization 
state of Ynm3. All HtrA family members, including Ynm3, form oligomers, with homo-
trimers as their basic building unit (Li et al., 2002; Wilken et al., 2004; Zhang et al., 
2017). Intriguingly, the bacterial homologue DegP changes from a “resting” hexamer 
to a 12 or 24mer upon substrate binding (Krojer et al., 2008b). In vitro Ynm3 appeared 
as a homotrimer forming a cage-like structure with the three protomers arranged in a 
C3 rotational symmetry (Zhang et al., 2017). Whether the state of Ynm3 
oligomerization changes upon substrate binding is yet to be uncovered. However, 
future in vitro structural analysis of Ynm3, in complex with Roq1, would allow us to 
investigate in detail the binding and cleavage properties of Ynm3. 
 
3.4 Regulation of Ynm3-mediated cleavage of Roq1 
Roq1 overexpression initiated a slower reporter degradation compared to reporter 
degradation upon stress treatments. These findings suggest that the stressors might 
directly or indirectly activate other processes that speed up SHRED and the 
degradation of misfolded proteins. 
Could Ynm3 processivity be stress-regulated? In vitro cryo-EM data proposes that 
Ynm3 exist in a dynamic equilibrium of open (substrate accepting) and closed 
(proteolytically non-active) conformational states (Zhang et al., 2017). Hypothetically, 
stress conditions might change this equilibrium to a more open and enzymatically 
active state which results in enhanced Roq1 cleavage and as a consequence Ubr1 
and SHRED activation. However, we cannot rule out that the stressors caused other 
secondary, non-SHRED related, effects that resulted in faster reporter degradation. 
Another layer of Ynm3 regulation could be achieved by its post-translational 
modification. The mammalian homologue HtrA2 is phosphorylated in the mitochondrial 
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inter-membrane space in a PINK1 dependent manner. This modification modulates its 
proteolytic activity (Plun-Favreau et al., 2007). Ynm3 is proposed to be phosphorylated 
at serine-993, which influences its function in apoptosis (unpublished results of the 
Fahrenkrog Lab, Fahrenkrog, 2011). Whether phosphorylation of Ynm3 exists and 
whether it has an effect on SHRED or Roq1 cleavage is yet to be determined. 
 
3.5 Cleaved Roq1 modulates Ubr1 substrate specificity 
The Roq1 cleavage fragment, with an N-terminal arginine residue, binds to and 
reprograms Ubr1 via the type-1 substrate-binding site. This binding modifies Ubr1 
substrate specificity resulting in a slower degradation of Cup9 and type-1 substrates 
and accelerated degradation of type-2 substrates and misfolded membrane or 
cytosolic proteins. How does Roq1 modulate Ubr1 substrate specificity? Bound Roq1 
might act as an allosteric regulator of Ubr1. Similar, allosteric regulation occurs when 
dipeptides bind synergistically to the Ubr1 type-1 and -2 site which relieves auto-
inhibition and leads to the degradation of Cup9 (Du et al., 2002). In case of SHRED, 
the activation of Ubr1 occurs strictly through the type-1 site. This raises the possibility 
that binding of Roq1 to the type-1 site alone initiates a conformational change in Ubr1 
that modulates its substrate binding capacity. Indeed, during activation of Ubr1 by 
dipeptides, the initial occupancy of the type-1 site induces a slight conformational 
change that increases the accessibility of the type-2 site (Du et al., 2002). Thus, the 
interaction of cleaved Roq1 with the type-1 site by itself could initiate structural changes 
within Ubr1, which are relevant for SHRED.  
The interaction between Roq1 and Ubr1 was clearly dependent on the N-terminal 
arginine of Roq1 and the type-1 site of Ubr1. However, it remains to be determined if 
additional features of Roq1 are also important for Ubr1 activation. Structural 
information on the yeast and human Ubr1 type-1 site suggests that it is a relatively 
shallow substrate-binding cleft (Choi et al., 2010; Matta-Camacho et al., 2010). 
Therefore, Roq1 might physically interact with other regions of Ubr1, which may be 
important to modulate substrate specificity of Ubr1. Truncations or random 
mutagenesis analysis of Roq1 would allow us to uncover further important regions or 
domains of Roq1 besides its N-terminus. Alternatively, Roq1 might act as a substrate 
adaptor: after its cleavage it interacts with Ubr1 at the type-1 site, which could offer a 
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new substrate-binding platform on Ubr1. This would enable direct delivery of SHRED 
substrates to Ubr1 for ubiquitylation and degradation. Further mechanistic experiments 
will be required to explore the full scope of how Roq1 modulates Ubr1 substrate 
specificity. 
 
3.6 Substrate recognition by Ubr1 
How does Ubr1 recognize misfolded proteins? Cytosolic misfolded proteins are 
reportedly presented to Ubr1 by the Hsp70 chaperone Ssa1 (Eisele and Wolf, 2008; 
Heck et al., 2010). However, in vitro experiments suggest that Ubr1 can also interact 
with and ubiquitylate misfolded substrates in the absence of chaperones as well 
(Nillegoda et al., 2010). If Ubr1 binds misfolded (SHRED) substrates directly, which 
part of Ubr1 is responsible for the interaction? Cup9 is proposed to bind to a third yet 
unidentified Ubr1 substrate-binding site (Du et al., 2002). Our mass spectrometry data 
suggest that Roq1 overexpression inhibits Ubr1-dependent degradation of Cup9 and 
simultaneously enhances degradation of misfolded proteins. This suggests that either 
the Cup9 site becomes inaccessible during Ubr1 activation by Roq1 or the SHRED 
substrates outcompete Cup9 for the same substrate-binding site resulting in its slower 
turnover. However, we cannot rule out that SHRED substrates may bind to an 
additional substrate-binding site, which could prevent the binding of Cup9 to Ubr1.  
How can the Ubr1 substrate-binding site be identified? Perturbations like point 
mutations or truncations in Ubr1 often render the entire protein non-functional (see the 
slight effect of type-1 site mutation on the degradation of type-2 substrates, Figure 
16B). Hence, mutational analysis of Ubr1 is challenging and might result in secondary 
indirect effects. An alternative approach could be the structural characterization of 
Ubr1, potentially in complex with Roq1 and/or misfolded proteins. Up to now, there is 
no structural information on the entire Ubr1 enzyme. With the current technological 
advancement in the cryo-EM field, the structural characterization of the entire Ubr1 
enzyme, might be possible in the near future.  
 
3.7 Dynamic regulation of SHRED 
Dynamic regulation of any given pathway requires that it can be rapidly switched on 
and off. This can be accomplished by the rapid transcriptional upregulation and quick 
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turnover of an important regulatory factor in the pathway. In case of SHRED this is 
achieved through Roq1. As discussed above, ROQ1 transcription is upregulated 
several fold during a wide variety of stresses in order to activate SHRED. On the other 
hand, the very short half-life of Roq1 protein enables rapid inactivation of SHRED as 
soon as stress subsides. This mode of pathway inactivation is similar to the UPR or 
the proteasome biogenesis pathway where the short half-life of transcription factors 
Hac1 and Rpn4 enables swift shut-off as soon as the inducing signal diminishes 
(Livneh et al., 2016; Walter and Ron, 2011).  
Furthermore, the short half-life of Roq1 offers another layer of SHRED regulation. Our 
results suggest that cleaved Roq1 is degraded by the proteasome but Ubr1 is only 
partially required for its degradation. This raises the first question: which ubiquitin 
ligase is required for the degradation of the Roq1 cleavage fragment? Interestingly, 
cleaved Roq1 does not contain any acceptor lysine that could be marked with a 
polyubiquitin chain. Thus, cleaved Roq1 has to be processed by a non-canonical 
ubiquitylation or has to be recognised and degraded by the proteasome without 
attachment of a polyubiquitin chain (Kravtsova-Ivantsiv and Ciechanover, 2012). It has 
been reported that cysteine, serine or threonine can be also used as an acceptor 
residue for polyubiquitin chains (Cadwell and Coscoy, 2005). Additionally, it has been 
shown that N-termini of target proteins can also obtain polyubiquitin chains 
(Breitschopf et al., 1998). However, the latter option is unlikely since the N-terminus of 
Roq1 is buried within type-1 substrate-binding cleft. The identification of the potential 
ubiquitin ligase of Roq1 and the mode of its degradation will enable us to dissect the 
post-transcriptional regulation of SHRED  
 
3.8 Stress-regulated protein quality control 
The main characteristic of the SHRED pathway is its stress regulation. Stress 
conditions increase the amount of misfolded proteins therefore, cells mount adaptive 
responses to re-establish protein homeostasis (Labbadia and Morimoto, 2015). From 
a metabolic point of view refolding or repairing a misfolded protein is energetically 
favourable over degradation and re-synthesis (Buchberger et al., 2010). However, 
during unfavourable conditions chaperone capacity and thus refolding activity might be 
limiting, therefore protein degradation is inevitable. We propose that SHRED is a 
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branch of ESR, and together with the UPR and HSR, adjusts protein quality pathways 
to aid in the removal of the increased amounts of misfolded and damaged proteins. 
When stress subsides and protein homeostasis is re-established SHRED is inactivated 
by the swift turnover of its main regulator Roq1.  
 
3.9 Could SHRED be evolutionary conserved? 
Roq1 was listed as an uncharacterized protein at the beginning of this PhD project. It 
belongs to a family of hydrophilin proteins whose defining characteristics are high 
hydrophobicity and high content of glycine, alanine and serine residues (Battaglia et 
al., 2008; Dang and Hincha, 2011). Moreover, hydrophilins are intrinsically disordered 
proteins and they do not share sequence homology between family members (Garay-
Arroyo et al., 2000). Most of the hydrophilins are found in the kingdom of Plantae but 
homologues are also found in Bacteria, Archea and Fungi (Battaglia et al., 2008). 
A search for Roq1 homologues, based on the amino acid sequence, does not yield 
any higher eukaryote homologues likely due to the absence of recognisable domain 
structures and the small molecular size of the Roq1 protein. However, the existence of 
functional analogues in metazoans cannot be excluded.  
As discussed above, Ynm3 has several homologues in the family of HtrA proteases 
(Clausen et al., 2011). Its bacterial homologues DegS/P function in protein quality 
control in the periplasm (Spiess et al., 1999) while the mammalian homologue HtrA2 
is involved in mitochondrial quality control and apoptosis (Vande Walle et al., 2008). 
Importantly, the human homologue HtrA2 is further implicated in ERAD (Huttunen et 
al., 2007).  
Ubr1 homologues are also found in many organisms ranging from yeast to humans 
(Varshavsky, 2011). As mentioned Ubr1 is the main ubiquitin E3 ligase involved in the 
N-end rule pathway but has emerging roles in cytosolic quality control as well. 
Importantly, it has been implicated in ERAD in the absence of Hrd1 and Doa10 or 
during stressful conditions (Heck et al., 2010; Stolz et al., 2013). In summary, although 
the existence of a higher eukaryote homologue of Roq1 is not obvious, both Ubr1 and 
Ynm3 are conserved in many organisms raising the possibility that SHRED-like 
mechanism might exist in metazoans as well. 
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Are there any biochemical pathways that show a SHRED-like regulatory principle? 
Human HtrA2 is expressed as a pro-enzyme and delivered to the mitochondria via a 
mitochondrial localization signal (Martins et al., 2002). In the mitochondrial inter-
membrane space, HtrA2 undergoes self-cleavage and upon apoptotic stimulus the C-
terminal cleavage fragment is released into the cytosol (Hegde et al., 2002). 
Intriguingly, the autocatalysis uncovers an N-terminal IAP binding motif that is required 
for HtrA2 to interact with the inhibitor-of-apoptosis protein XIAP in the cytosol (Martins, 
2002). XIAP is a RING domain ubiquitin E3 ligase that inhibits and degrades important 
caspases in the apoptotic pathway (Silke and Meier, 2013). Binding of cleaved HtrA2 
to XIAP inhibits its E3 ligase function (Martins, 2002). This could be considered 
analogous to SHRED: a proteolytic cleavage uncovers an N-terminal motif that is 
required for the binding to and reprograming of a ubiquitin E3 ligase. These intriguing 
observations suggest that SHRED-like mechanistic regulation of ubiquitin E3 ligases 
might also exist in higher eukaryotes.  
 
3.10 Endogenous substrates of SHRED 
Our genetic screen and mass spectrometry analysis revealed that SHRED is not only 
responsible for the degradation of misfolded proteins but also for the removal of 
endogenous and potentially well-folded proteins. Both screening approaches offered 
endogenous candidate substrates for SHRED. However, only Sfa1 was identified as a 
candidate substrate with both approaches. A likely explanation for the small overlap is 
the distinct principle of the two screening approaches. The tandem fluorescent timer 
(tFT) tag approach enables direct analysis of protein half-lives via the mCherry over 
sfGFP fluorescence intensity ratio. However, the large size of the tFT tag could 
interfere with folding and the function of the protein of interest. This might introduce 
false positive hits resulting from misfolding caused by the large bulky tag. In the mass 
spectrometry approach the candidate substrates were not tagged, thereby bypassing 
this limitation of the tFT screen. However, the mass spectrometry analysis measures 
total protein levels from which the half-life of any given protein cannot be calculated. 
Moreover, Roq1 overexpression induced a weaker reporter degradation: the reporter 
levels dropped by 35% in the mass spectrometry analysis, compared to the drop by 
60% in the tFT screen. Therefore, the dynamic range of this screen was rather small 
which might conceal weaker hits.  
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The two most prominent hits from the tFT screen, Cam1 and Tef4, were validated as 
a candidate substrate of SHRED by western blotting. Both proteins become a SHRED 
substrate when cells grow into post-diauxic phase. What could be the physiological 
relevance of this degradation phenotype? The transcriptome and the proteome of 
budding yeast is remodelled dramatically during growth into post-diauxic phase and to 
stationary phase (Gasch et al., 2000; Murphy et al., 2015). The transcriptional 
response involves the upregulation of trehalose and glycogen synthetases and 
enzymes involved in the tricarboxylic acid and glyoxylate cycle. In contrast, general 
translation and translation of ribosomal proteins, tRNA synthetases and translation 
initiation and elongation factors are repressed (DeRisi et al., 1997; Murphy et al., 
2015). Both CAM1 (also called TEF3) and TEF4 encode a subunit of the translation 
elongation factor eEF1B (Kambouris et al., 1993; Kinzy et al., 1994). These genes are 
transcriptionally downregulated during post-diauxic phase resulting in a positive 
feedback loop to inactivate general translation (Gasch et al., 2000). However, after the 
transcriptional downregulation of a gene the cells still have to remove the translated 
proteins as well. ROQ1 transcription is upregulated during post-diauxic phase and 
entry into stationary phase (Brauer et al., 2005; Segal et al., 2003) suggesting that 
SHRED is active during post-diauxic phase. Therefore, we propose that SHRED is 
involved in the remodelling of the proteome during growth into saturation. In summary, 
SHRED is not only required for protein quality control but also for abundance control 
of proteins during certain physiological conditions. 
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MATERIALS AND METHODS 
4.1 Materials 
Table 1. Plasmids used in the study 
Alias Plasmid name Source/Reference 
pSS077 pFA6a-Pho8∆60-kanMX6 this study 
pSS078 pFA6a-Pho8∆60(F352S)-kanMX6 this study 
pMaM227 pRS303K-TDH3pr-TagBFP Michael Knop 
pMaM245 pRS303H-TDH3pr-TagBFP Michael Knop 
pSS665 pRS305-ADH1pr-Pho8* this study 
pSS421 pRS305-ADH1pr-Rtn1-FLAG-sfGFP this study 
pSS422 pRS305-ADH1pr-Rtn1-Pho8*-FLAG-sfGFP this study 
pSS450 pRS305-ADH1pr-Rtn1-CPY*-FLAG-sfGFP this study 
pSS483 pRS305-ADH1pr-Hmg2-FLAG-sfGFP this study 
pSS170 pRS305-ADH1pr-Rtn1-FLAG-GFP this study 
pSS174 pRS305-ADH1pr-Rtn1-Pho8*-FLAG-GFP this study 
pSS411 pRS305-GAL1pr-Rtn1-FLAG-sfGFP this study 
pSS412 pRS305-GAL1pr-Rtn1-Pho8*-FLAG-sfGFP this study 
pDEP001 pRS306-ADH1pr-GEM(Gal4DBD-EstR-Msn2TAD) Pincus et al., 2014 
pDEP151 pNH605-ADH1pr-GEM(Gal4DBD-EstR-Msn2TAD) David Pincus 
pSS252 pRS316-CYCter this study 
pSS255 pRS316-YNM3pr-Ynm3 this study 
pSS257 pRS316-YNM3pr-ynm3(S236A) this study 
pSS352 pRS316-YNM3pr-Ynm3-GFP this study 
pSS254 pRS316-ROQ1pr-Roq1  this study 
pSS629 pRS316-ROQ1pr-Roq1-HA this study 
pSS776 pRS316-ROQ1pr-Roq1-HA(74) this study 
pSS634 pRS416-TDH3pr-Roq1-HA this study 
pSS649 pRS416-TDH3pr-Roq1-HA(74) this study 
pSS784 pRS416-TDH3pr-Ub-Roq1∆18-HA(74) this study 
pSS762 pRS416-TDH3pr-Ub-Roq1∆19-HA(74) this study 
pSS763 pRS416-TDH3pr-Ub-Roq1∆20-HA(74) this study 
pSS764 pRS416-TDH3pr-Ub-Roq1∆21-HA(74) this study 
pSS927 pRS416-TDH3pr-Ub-roq1∆21(R22A)-HA(74) this study 
pSS765 pRS416-TDH3pr-Ub-Roq1∆22-HA(74) this study 
pSS766 pRS416-TDH3pr-Ub-Roq1∆23-HA(74) this study 
pSS734 pRS316-ROQ1pr-Ub-Roq1 this study 
pSS804 pRS316-ROQ1pr-Ub-Roq1∆7 this study 
pSS805 pRS316-ROQ1pr-Ub-Roq1∆8 this study 
pSS806 pRS316-ROQ1pr-Ub-Roq1∆9 this study 
pSS745 pRS316-ROQ1pr-Ub-Roq1∆10 this study 
pSS746 pRS316-ROQ1pr-Ub-Roq1∆11 this study 
pSS747 pRS316-ROQ1pr-Ub-Roq1∆12 this study 
pSS748 pRS316-ROQ1pr-Ub-Roq1∆13 this study 
pSS749 pRS316-ROQ1pr-Ub-Roq1∆14 this study 
pSS750 pRS316-ROQ1pr-Ub-Roq1∆15 this study 
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pSS751 pRS316-ROQ1pr-Ub-Roq1∆16 this study 
pSS752 pRS316-ROQ1pr-Ub-Roq1∆17 this study 
pSS753 pRS316-ROQ1pr-Ub-Roq1∆18 this study 
pSS754 pRS316-ROQ1pr-Ub-Roq1∆19 this study 
pSS755 pRS316-ROQ1pr-Ub-Roq1∆20 this study 
pSS756 pRS316-ROQ1pr-Ub-Roq1∆21 this study 
pSS757 pRS316-ROQ1pr-Ub-Roq1∆22 this study 
pSS771 pRS316-ROQ1pr-Ub-Roq1∆23 this study 
pSS772 pRS316-ROQ1pr-Ub-Roq1∆24 this study 
pSS773 pRS316-ROQ1pr-Ub-Roq1∆25 this study 
pSS827 pRS316-ROQ1pr-Ub-roq1∆21(R22A) this study 
pSS830 pRS316-ROQ1pr-Ub-roq1∆21(R22L) this study 
pSS829 pRS316-ROQ1pr-Ub-roq1∆21(R22K) this study 
pSS834 pRS316-ROQ1pr-roq1(L21P)-HA(74) this study 
pSS845 pRS316-ROQ1pr-roq1(L21V)-HA(74) this study 
pSS796 pRS316-TDH3pr-roq1(L21P)-HA(74) this study 
pSS797 pRS316-TDH3pr-roq1(L21V)-HA(74) this study 
pSS256 pRS316-UBR1pr-Ubr1 this study 
pSS617 pRS316-UBR1pr-ubr1(G173R) this study 
pSS374 pRS316-UBR1pr-ubr1(D318N) this study 
pSS930 pRS415-ADH1pr-FLAG-Ubr1 this study 
pSS935 pRS415-ADH1pr-FLAG-ubr1(G173R) this study 
pSS938 pRS415-ADH1pr-FLAG-ubr1(C1220S) this study 
pSS669 pFA6a-kanMX6-GEM,GAL1pr this study 
pAK146 pRS306K-TDH3pr-Ub-A-mCherry-sfGFP Khmelinskii et al., 2012 
pAK147 pRS306K-TDH3pr-Ub-C-mCherry-sfGFP Khmelinskii et al. 2012 
pAK148 pRS306K-TDH3pr-Ub-D-mCherry-sfGFP Khmelinskii et al. 2012 
pAK149 pRS306K-TDH3pr-Ub-E-mCherry-sfGFP Khmelinskii et al. 2012 
pMaM48 pRS306K-TDH3pr-Ub-F-mCherry-sfGFP Khmelinskii et al. 2012 
pAK150 pRS306K-TDH3pr-Ub-G-mCherry-sfGFP Khmelinskii et al. 2012 
pAK151 pRS306K-TDH3pr-Ub-H-mCherry-sfGFP Khmelinskii et al. 2012 
pMaM47 pRS306K-TDH3pr-Ub-I-mCherry-sfGFP Khmelinskii et al. 2012 
pAK152 pRS306K-TDH3pr-Ub-K-mCherry-sfGFP Khmelinskii et al. 2012 
pAK153 pRS306K-TDH3pr-Ub-L-mCherry-sfGFP Khmelinskii et al. 2012 
pMaM46 pRS306K-TDH3pr-Ub-M-mCherry-sfGFP Khmelinskii et al. 2012 
pAK154 pRS306K-TDH3pr-Ub-N-mCherry-sfGFP Khmelinskii et al. 2012 
pAK155 pRS306K-TDH3pr-Ub-P-mCherry-sfGFP Khmelinskii et al. 2012 
pAK156 pRS306K-TDH3pr-Ub-Q-mCherry-sfGFP Khmelinskii et al. 2012 
pMaM66 pRS306K-TDH3pr-Ub-R-mCherry-sfGFP Khmelinskii et al. 2012 
pAK157 pRS306K-TDH3pr-Ub-S-mCherry-sfGFP Khmelinskii et al. 2012 
pAK158 pRS306K-TDH3pr-Ub-T-mCherry-sfGFP Khmelinskii et al. 2012 
pAK159 pRS306K-TDH3pr-Ub-V-mCherry-sfGFP Khmelinskii et al. 2012 
pAK160 pRS306K-TDH3pr-Ub-W-mCherry-sfGFP Khmelinskii et al. 2012 
pMaM67 pRS306K-TDH3pr-Ub-Y-mCherry-sfGFP Khmelinskii et al. 2012 
pSS666 pRS305-ADH1pr-Yop1-Pho8*-FLAG-sfGFP this study 
pSS608 pRS305-ADH1pr-Yop1-Pho8*-FLAG-GFP this study 
pSS607 pRS305-ADH1pr-Rtn1-CPY*-FLAG-GFP this study 
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Alias Plasmid name Source/Reference 
pSM1152 pRS426-PGK1pr-CFTR-HA Zhang et al., 2001 
SSY664 pRS306N-TEF1pr-NES-Luciferase-mCherry this study 
SSY637 pRS306N-TEF1pr-NES-Luciferase(DM)-mCherry this study 
SSY653 pRS306N-TEF1pr-stGnd1-mCherry this study 
 
Table 2. Yeast strains used in the study 
For strains containing centromeric or 2µ plasmids only the genotype of the parent 
strains are listed. The chromosomally integrated different Ub-X-mCherry-sfGFP 
substrates are generated in strain SSY1856 (WT), SSY1857 (ubr1∆) and SSY1858 
(ynm3∆). 
Alias Genotype Source 
SSY122 MATa ADE2 leu2-3,112 trp1-1 ura3-1 his3-11,15 (W303) lab collection 
SSY765 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 (BY4741) lab collection 
SSY2353 MATα his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 (BY4742) lab collection 
YJLM11-1 BY4741 can1∆::STE2pr-SpHIS5 lyp1∆::STE3pr-LEU2 URA3 Knop Lab 
YMaM330 BY4742 can1∆::STE2pr-SpHIS5 lyp1∆::STE3pr-LEU2 leu2∆::GAL1pr-I-SCEI-natR Knop Lab 
SSY689 pho13∆::HIS3 PHO8::kanR this study 
SSY690 pho13∆::HIS3 pho8(F352S)::kanR this study 
SSY995 pho13∆::HIS3 PHO8::kanR hrd1∆::natR this study 
SSY996 pho13∆::HIS3 pho8(F352S)::kanR hrd1∆::natR this study 
SSY1624 HIS3::TDH3pr-BFP-hphR LEU2::ADH1pr-Pho8* this study 
SSY1632 HIS3::TDH3pr-BFP-hphR san1∆::kanR LEU2::ADH1pr-Pho8* this study 
SSY954 HIS3::TDH3pr-BFP-hphR Sec63-mCherry::HIS3 this study 
SSY1189 HIS3::TDH3pr-BFP-hphR Sec63-mCherry::HIS3 LEU2::ADH1pr-Rtn1-sfGFP  this study 
SSY1191 HIS3::TDH3pr-BFP-hphR Sec63-mCherry::HIS3 LEU2::ADH1pr-Rtn1CPY*-sfGFP  this study 
SSY1190 HIS3::TDH3pr-BFP-hphR Sec63-mCherry::HIS3 LEU2::ADH1pr-Rtn1Pho8*-sfGFP  this study 
SSY1160 HIS3::TDH3pr-BFP-hphR LEU2::ADH1pr-Hmg2-sfGFP this study 
SSY1020 HIS3::TDH3pr-BFP-hphR LEU2::ADH1pr-Rtn1-sfGFP this study 
SSY1143 HIS3::TDH3pr-BFP-hphR LEU2::ADH1pr-Rtn1CPY*-sfGFP this study 
SSY1022 HIS3::TDH3pr-BFP-hphR LEU2::ADH1pr-Rtn1Pho8*-sfGFP this study 
SSY829 HIS3::TDH3pr-BFP-hphR LEU2::ADH1pr-Rtn1-GFP this study 
SSY831 HIS3::TDH3pr-BFP-hphR LEU2::ADH1pr-Rtn1Pho8*-GFP this study 
SSY965 HIS3::TDH3pr-BFP-hphR LEU2::GAL1pr-Rtn1-sfGFP this study 
SSY967 HIS3::TDH3pr-BFP-hphR LEU2::GAL1pr-Rtn1Pho8*-sfGFP this study 
SSY2354 HIS3::TDH3pr-BFP-hphR LEU2::GAL1pr-Rtn1-sfGFP Sec63-mCherry::HIS3 this study 
SSY2355 HIS3::TDH3pr-BFP-hphR LEU2::GAL1pr-Rtn1Pho8*-sfGFP Sec63-mCherry::HIS3 this study 
SSY1084 HIS3::TDH3pr-BFP-hphR LEU2::GAL1pr-Rtn1-sfGFP Rtn1-mCherry::HIS3 this study 
SSY1086 HIS3::TDH3pr-BFP-hphR LEU2::GAL1pr-Rtn1Pho8*-sfGFP Rtn1-mCherry::HIS3 this study 
SSY822 HIS3::TDH3pr-BFP-hphR pdr5∆::HIS3 LEU2::ADH1pr-Rtn1Pho8*-GFP this study 
SSY843 HIS3::TDH3pr-BFP-hphR pep4∆::TRP1 prb1∆::HIS3 LEU2::ADH1pr-Rtn1Pho8*-GFP this study 
SSY901 HIS3::TDH3pr-BFP-hphR hrd1∆::HIS3 doa10∆::TRP1 pdr5∆::kanR LEU2::ADH1pr-Rtn1Pho8*-GFP this study 
SSY875 his3∆::HIS3 this study 
SSY1782 ubr1∆::HIS3 this study 
SSY772 ynm3∆::HIS3 this study 
SSY1729 roq1∆::HIS3 this study 
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SSY644 MAT atg7∆::TRP1 LEU2::ADH1pr-Rtn1Pho8*-GFP  this study 
SSY833 HIS3::TDH3pr-BFP-hphR ubr1∆::natR LEU2::ADH1pr-Rtn1Pho8*-GFP this study 
SSY834 HIS3::TDH3pr-BFP-hphR ynm3∆::HIS3 LEU2::ADH1pr-Rtn1Pho8*-GFP this study 
SSY835 HIS3::TDH3pr-BFP-hphR roq1∆::kanR LEU2::ADH1pr-Rtn1Pho8*-GFP this study 
SSY970 HIS3::TDH3pr-BFP-hphR ubr1∆::natR LEU2::GAL1pr-Rtn1Pho8*-sfGFP this study 
SSY969 HIS3::TDH3pr-BFP-hphR ynm3∆::HIS3 LEU2::GAL1pr-Rtn1Pho8*-sfGFP this study 
SSY971 HIS3::TDH3pr-BFP-hphR roq1∆::kanR LEU2::GAL1pr-Rtn1Pho8*-sfGFP this study 
SSY836 HIS3::TDH3pr-BFP-hphR ubr1∆::natR ynm3∆::HIS3 LEU2::ADH1pr-Rtn1Pho8*-GFP this study 
SSY837 HIS3::TDH3pr-BFP-hphR ubr1∆::natR roq1∆::HIS3 LEU2::ADH1pr-Rtn1Pho8*-GFP this study 
SSY838 HIS3::TDH3pr-BFP-hphR ynm3∆::HIS3 roq1∆::kanR LEU2::ADH1pr-Rtn1Pho8*-GFP this study 
SSY839 HIS3::TDH3pr-BFP-hphR pdr5∆::HIS3 ubr1∆::natR LEU2::ADH1pr-Rtn1Pho8*-GFP this study 
SSY840 HIS3::TDH3pr-BFP-hphR pdr5∆::kanR ynm3∆::HIS3 LEU2::ADH1pr-Rtn1Pho8*-GFP this study 
SSY841 HIS3::TDH3pr-BFP-hphR pdr5∆::HIS3 roq1∆::kanR LEU2::ADH1pr-Rtn1Pho8*-GFP this study 
SSY1202 HIS3::TDH3pr-BFP-kanR rad6∆::natR LEU2::ADH1pr-Rtn1Pho8*-GFP this study 
SSY1248 HIS3::TDH3pr-BFP-hphR ubr2∆::kanR LEU2::ADH1pr-Rtn1Pho8*-GFP this study 
SSY1250 HIS3::TDH3pr-BFP-hphR san1∆::kanR LEU2::ADH1pr-Rtn1Pho8*-GFP this study 
SSY1251 HIS3::TDH3pr-BFP-hphR ubr1∆::natR san1∆::kanR LEU2::ADH1pr-Rtn1Pho8*-GFP this study 
SSY1012 BY4741 cdc48-3::kanR Charles Boone 
SSY1278 BY4741 HIS3::TDH3pr-BFP-hphR ura3∆::GAL1pr-Rtn1Pho8*-sfGFP-LEU2 this study 
SSY1279 BY4741 cdc48-3::kanR HIS3::TDH3pr-BFP-hphR ura3∆::GAL1pr-Rtn1Pho8*-sfGFP-LEU2 this study 
SSY1239 HIS3::TDH3pr-BFP-hphR ire1∆::kanR LEU2::ADH1pr-Rtn1Pho8*-GFP this study 
SSY1240 HIS3::TDH3pr-BFP-hphR hac1∆::HIS3 LEU2::ADH1pr-Rtn1Pho8*-GFP this study 
SSY1482 tpk1/2/3-as  
Hao and 
O’Shea, 2012 
SSY1484 tpk1/2/3-as HIS3::TDH3pr-BFP-hphR this study 
SSY1551 tpk1/2/3-as HIS3::TDH3pr-BFP-hphR LEU2::ADH1pr-Rtn1Pho8*-GFP this study 
SSY1552 tpk1/2/3-as HIS3::TDH3pr-BFP-hphR ubr1∆::hphR LEU2::ADH1pr-Rtn1Pho8*-GFP this study 
SSY1553 tpk1/2/3-as HIS3::TDH3pr-BFP-hphR ynm3∆::hphR LEU2::ADH1pr-Rtn1Pho8*-GFP this study 
SSY1554 tpk1/2/3-as HIS3::TDH3pr-BFP-hphR roq1∆::hphR LEU2::ADH1pr-Rtn1Pho8*-GFP this study 
SSY920 HIS3::TDH3pr-BFP-hphR URA3::GEM this study 
SSY1488 HIS3::TDH3pr-BFP-hphR LEU2::ADH1pr-Rtn1Pho8*-GFP URA3::GEM this study 
SSY2143 HIS3::TDH3pr-BFP-hphR LEU2::ADH1pr-Rtn1Pho8*-GFP URA3::GEM ubr1∆::natR this study 
SSY1559 HIS3::TDH3pr-BFP-hphR LEU2::ADH1pr-Rtn1Pho8*-GFP URA3::GEM kanR::GAL1pr-ROQ1 this study 
SSY1561 
HIS3::TDH3pr-BFP-hphR LEU2::ADH1pr-Rtn1Pho8*-GFP URA3::GEM kanR::GAL1pr-ROQ1 
ubr1∆::natR 
this study 
SSY1560 
HIS3::TDH3pr-BFP-hphR LEU2::ADH1pr-Rtn1Pho8*-GFP URA3::GEM kanR::GAL1pr-ROQ1 
ynm3∆::natR 
this study 
SSY1762 HIS3::TDH3pr-BFP-hphR LEU2::ADH1pr-Rtn1-GFP URA3::GEM this study 
SSY2030 HIS3::TDH3pr-BFP-hphR LEU2::ADH1pr-Rtn1-GFP URA3::GEM kanR::GAL1pr-ROQ1 this study 
SSY1490 Ynm3-GFP::HIS3 Sec63-mCherry::kanR this study 
SSY760 pdr5∆::HIS3 this study 
SSY791 ynm3∆::HIS3 pdr5∆::kanR this study 
SSY838 HIS3::TDH3pr-BFP-hphR ynm3∆::HIS3 roq1∆::kanR LEU2::ADH1pr-Rtn1Pho8*-GFP this study 
SSY792 ubr1∆::natR roq1∆::HIS3 this study 
SSY2323 ubr1∆::natR roq1∆::HIS3 ura3∆::TDH3pr-Ub-roq1∆21-HA(74)-URA3 this study 
SSY2324 ubr1∆::natR roq1∆::HIS3 ura3∆::TDH3pr-Ub-roq1(R22A)∆21-HA(74)-URA3 this study 
SSY1856 HIS3::TDH3pr-BFP-hphR natR::GEM,GAL1pr-ROQ1 this study 
SSY1857 HIS3::TDH3pr-BFP-hphR natR::GEM,GAL1pr-ROQ1 ubr1∆::HIS3 this study 
SSY1858 HIS3::TDH3pr-BFP-hphR natR::GEM,GAL1pr-ROQ1 ynm3∆::HIS3 this study 
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SSY2376 
ubr1∆::natR roq1∆::HIS3 ura3∆::TDH3pr-Ub-roq1∆21-HA(74)-ura3::TDH3pr-Ub-R-mCherry-sfGFP-
kanR 
this study 
SSY1621 HIS3::TDH3pr-BFP-hphR LEU2::ADH1pr-Yop1Pho8*-sfGFP this study 
SSY1393 HIS3::TDH3pr-BFP-hphR LEU2::ADH1pr-Yop1Pho8*-GFP this study 
SSY1394 HIS3::TDH3pr-BFP-hphR ubr1∆::natR LEU2::ADH1pr-Yop1Pho8*-GFP this study 
SSY1395 HIS3::TDH3pr-BFP-hphR ynm3∆::HIS3 LEU2::ADH1pr-Yop1Pho8*-GFP this study 
SSY1396 HIS3::TDH3pr-BFP-hphR roq1∆::kanR LEU2::ADH1pr-Yop1Pho8*-GFP this study 
SSY1388 HIS3::TDH3pr-BFP-hphR LEU2::ADH1pr-Rtn1CPY*-GFP this study 
SSY1389 HIS3::TDH3pr-BFP-hphR ubr1∆::natR LEU2::ADH1pr-Rtn1CPY*-GFP this study 
SSY1390 HIS3::TDH3pr-BFP-hphR ynm3∆::HIS3 LEU2::ADH1pr-Rtn1CPY*-GFP this study 
SSY1391 HIS3::TDH3pr-BFP-hphR roq1∆::kanR LEU2::ADH1pr-Rtn1CPY*-GFP this study 
SSY800 HIS3::TDH3pr-BFP-hphR hrd1∆::HIS3 doa10∆::TRP1 this study 
SSY816 HIS3::TDH3pr-BFP-hphR hrd1∆::HIS3 doa10∆::TRP1 ubr1∆::natR this study 
SSY860 HIS3::TDH3pr-BFP-hphR hrd1∆::HIS3 doa10∆::TRP1 ynm3∆::natR this study 
SSY861 HIS3::TDH3pr-BFP-hphR hrd1∆::HIS3 doa10∆::TRP1 roq1∆::kanR this study 
SSY1577 HIS3::TDH3pr-BFP-hphR ura3::TEF1pr-Luciferase-mCherry-natR this study 
SSY1521 HIS3::TDH3pr-BFP-hphR ura3::TEF1pr-Luciferase(DM)-mCherry-natR this study 
SSY1522 HIS3::TDH3pr-BFP-hphR ubr1∆::kanR ura3::TEF1pr-Luciferase(DM)-mCherry-natR this study 
SSY1523 HIS3::TDH3pr-BFP-hphR ynm3∆::HIS3 ura3::TEF1pr-Luciferase(DM)-mCherry-natR this study 
SSY1524 HIS3::TDH3pr-BFP-hphR roq1∆::kanR ura3::TEF1pr-Luciferase(DM)-mCherry-natR this study 
SSY2031 HIS3::TDH3pr-BFP-hphR ura3::TEF1pr -Luciferase-mCherry-natR LEU2::GEM this study 
SSY2033 HIS3::TDH3pr-BFP-hphR ura3::TEF1pr -Luciferase-mCherry-natR LEU2::GEM kanR::GAL1pr-ROQ1 this study 
SSY2032 HIS3::TDH3pr-BFP-hphR ura3::TEF1pr-Luciferase(DM)-mCherry-natR LEU::GEM this study 
SSY2034 
HIS3::TDH3pr-BFP-hphR ura3::TEF1pr-Luciferase(DM)-mCherry-natR LEU::GEM kanR::GAL1pr-
ROQ1 
this study 
SSY1572 HIS3::TDH3pr-BFP-hphR ura3::TEF1pr-stGnd1-mCherry-natR this study 
SSY1573 HIS3::TDH3pr-BFP-hphR ubr1∆::kanR ura3::TEF1pr-stGnd1-mCherry-natR this study 
SSY1574 HIS3::TDH3pr-BFP-hphR ynm3∆::HIS3 ura3::TEF1pr-stGnd1-mCherry-natR this study 
SSY1575 HIS3::TDH3pr-BFP-hphR roq1∆::kanR ura3::TEF1pr-stGnd1-mCherry-natR this study 
SSY1588 BY4741 HIS3::TDH3pr-BFP-hphR ura3∆::kanR  this study 
SSY1590 BY4741 HIS3::TDH3pr-BFP-hphR roq1∆::kanR  this study 
SSY1745 YJLM11-1 HIS3::TDH3pr-BFP-hphR URA3::TEF1pr-Rtn1-mCherry-sfGFP-natR this study 
SSY1747 YJLM11-1 HIS3::TDH3pr-BFP-hphR roq1∆::kanR URA3::TEF1pr-Rtn1-mCherry-sfGFP-natR this study 
SSY1748 YJLM11-1 HIS3::TDH3pr-BFP-hphR URA3::TEF1pr-Rtn1Pho8*-mCherry-sfGFP-natR this study 
SSY1750 YJLM11-1 HIS3::TDH3pr-BFP-hphR roq1∆::kanR URA3::TEF1pr-Rtn1Pho8*-mCherry-sfGFP-natR this study 
SSY1754 YMAM-330 MATa HIS3::TDH3pr-BFP-hphR ura3∆::kanR Cam1-mCherry-sfGFP this study 
SSY1756 YMAM-330 MATa HIS3::TDH3pr-BFP-hphR roq1∆::kanR Cam1-mCherry-sfGFP this study 
SSY1751 YMAM-330 MATa HIS3::TDH3pr-BFP-hphR ura3∆::kanR Tef4-mCherry-sfGFP this study 
SSY1753 YMAM-330 MATa HIS3::TDH3pr-BFP-hphR roq1∆::kanR Tef4-mCherry-sfGFP this study 
SSY2380 YMAM-330 MATa HIS3::TDH3pr-BFP-hphR ura3∆::kanR Sfa1-mCherry-sfGFP this study 
SSY2381 YMAM-330 MATa HIS3::TDH3pr-BFP-hphR roq1∆::kanR Sfa1-mCherry-sfGFP this study 
SSY2378 YMAM-330 MATa HIS3::TDH3pr-BFP-hphR ura3∆::kanR Glo1-mCherry-sfGFP this study 
SSY2379 YMAM-330 MATa HIS3::TDH3pr-BFP-hphR roq1∆::kanR Glo1-mCherry-sfGFP this study 
SSY1711 Cam1-HA::HIS3 this study 
SSY1714 Cam1-HA::HIS3 ubr1∆::natR this study 
SSY1715 Cam1-HA::HIS3 ynm3∆::natR this study 
SSY1716 Cam1-HA::HIS3 roq1∆::natR this study 
SSY1712 Tef4-HA::HIS3 this study 
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Alias Genotype Source 
SSY1718 Tef4-HA::HIS3 ubr1∆::natR this study 
SSY1719 Tef4-HA::HIS3 ynm3∆::natR this study 
SSY1720 Tef4-HA::HIS3 roq1∆::natR this study 
 
Table 3. Oligos used in the study 
Only the oligos used to create knockout or knock-in strains and the oligos used in 
qPCR experiments are listed here. Sequences of oligos used for cloning are available 
upon request. 
Name Sequence 
Knockout oligos 
ATG7-F1 ATGTCGTCAGAAAGGGTCTTAAGTTATGCACCAGCTTTTACGGATCCCCGGGTTAATTAA 
ATG7-R1 TGGCACCACAATATGTACCAATGCTATTATATGCAAAATAGAATTCGAGCTCGTTTAAAC 
DOA10-F1 TACCACTAATTGAATCAAAGAGACTAGAAGTGTGAAAGTCCGGATCCCCGGGTTAATTAA 
DOA10-R1 TATGCTAGCATTCATTTTAAATGTAAGGAAGAAAACGCCTGAATTCGAGCTCGTTTAAAC 
HAC1-F1 ACAACCTCCTCCTCCCCCACCTACGACAACAACCGCCACTCGGATCCCCGGGTTAATTAA 
HAC1-R1 ATAACGAGAAAAAAAAAATTATACCCTCTTGCGATTGTCTGAATTCGAGCTCGTTTAAAC 
HIS3-F1 TATACTAAAAAATGAGCAGGCAAGATAAACGAAGGCAAAGCGGATCCCCGGGTTAATTAA 
HIS3-R1 TATATATATCGTATGCTGCAGCTTTAAATAATCGGTGTCAGAATTCGAGCTCGTTTAAAC 
HRD1-F1 TGCAATTTGTAAGAGAAGGGGAGAAAGACAAAATAATAATCGGATCCCCGGGTTAATTAA 
HRD1-R1 TTTCTTTAAAAAAAACTATGTATAATATAAAACATGCAATGAATTCGAGCTCGTTTAAAC 
IRE1-F1 ACAGCATATCTGAGGAATTAATATTTTAGCACTTTGAAAACGGATCCCCGGGTTAATTAA 
IRE1-R1 GCAATAATCAACCAAGAAGAAGCAGAGGGGCATGAACATGGAATTCGAGCTCGTTTAAAC 
PDR5-F1 AAGTTTTCGTATCCGCTCGTTCGAAAGACTTTAGACAAAACGGATCCCCGGGTTAATTAA 
PDR5-R1 TCTTGGTAAGTTTCTTTTCTTAACCAAATTCAAAATTCTAGAATTCGAGCTCGTTTAAAC 
PEP4-F1 ATTTAATCCAAATAAAATTCAAACAAAAACCAAAACTAACCGGATCCCCGGGTTAATTAA 
PEP4-R1 GGCAGAAAAGGATAGGGCGGAGAAGTAAGAAAAGTTTAGCGAATTCGAGCTCGTTTAAAC 
PHO13-F1 CTTATAGCTTGCCCTGACAAAGAATATACAACTCGGGAAACGGATCCCCGGGTTAATTAA 
PHO13-R1 TTCAAAAAGTAATTCTACCCCTAGATTTTGCATTGCTCCTGAATTCGAGCTCGTTTAAAC 
PRB1-F1 CAATAAAAAAACAAACTAAACCTAATTCTAACAAGCAAAGCGGATCCCCGGGTTAATTAA 
PRB1-R1 AAGAAAAAAAAAAGCAGCTGAAATTTTTCTAAATGAAGAAGAATTCGAGCTCGTTTAAAC 
RAD6-S1 AAGATTATTTTTAGGCAGACAGAGACTAAAAGATAAAGCGTCCGTACGCTGCAGGTCGAC 
RAD6-S2 TATCGGCTCGGCATTCATCATTAAGATTCTTTTGATTTTTCATCGATGAATTCGAGCTCG 
ROQ1-F1 AAAAGTCAGCAAAAACAAGAGATAAGATAACAAGAAGAAGCGGATCCCCGGGTTAATTAA 
ROQ1-R1 CCCGAATGGTATTGTTAGATATGCTTTATAATGCTGGAGTGAATTCGAGCTCGTTTAAAC 
ROQ1-S1 AAAAAAGTCAGCAAAAACAAGAGATAAGATAACAAGAAGAAGCGTACGCTGCAGGTCGAC 
ROQ1-S2 ACCCGAATGGTATTGTTAGATATGCTTTATAATGCTGGAGTATCGATGAATTCGAGCTCG 
SAN1-F1 GTTTTCTCTCATAGTCTTGTAACCTCAGCTTTTGTTCATTCGGATCCCCGGGTTAATTAA 
SAN1-R1 GACATATTTTCATATTAACATACTTCAGAAGCGGTATTGTGAATTCGAGCTCGTTTAAAC 
UBR1-F1 AATCTTTACAGGTCACACAAATTACATAGAACATTCCAATCGGATCCCCGGGTTAATTAA 
UBR1-R1 ACAAATATGTCAACTATAAAACATAGTAGAGGGCTTGAATGAATTCGAGCTCGTTTAAAC 
UBR1-S1 CTAATCTTTACAGGTCACACAAATTACATAGAACATTCCAATCGTACGCTGCAGGTCGAC 
UBR1-S2 TACAAATATGTCAACTATAAAACATAGTAGAGGGCTTGAATATCGATGAATTCGAGCTCG 
UBR2-F1 AGATTCGTTAACTAAATTAATAGCTACTTAACAAGCACGCCGGATCCCCGGGTTAATTAA 
UBR2-R1 TTTCGTAGCAATTTTGAATGACTAGACATTTGTTGGATAAGAATTCGAGCTCGTTTAAAC 
pURA3-F1 ATTTATGGTGAAGGATAAGTTTTGACCATCAAAGAAGGTTCGGATCCCCGGGTTAATTAA 
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Name Sequence 
pURA3-R1 GAAGCTTTTTCTTTCCAATTTTTTTTTTTTCGTCATTATAGAATTCGAGCTCGTTTAAAC 
YNM3-F1 TACACACGTAGAGTACAGTAAAGGTTTTTTAGATCTACTACGGATCCCCGGGTTAATTAA 
YNM3-R1 CATACATACATACATATATAAATGTTTTATCAAATCTGGCGAATTCGAGCTCGTTTAAAC 
YNM3-S1 AATACACACGTAGAGTACAGTAAAGGTTTTTTAGATCTACTACGTACGCTGCAGGTCGAC 
YNM3-S2 ACATACATACATACATATATAAATGTTTTATCAAATCTGGCATCGATGAATTCGAGCTCG 
Knock-in oligos  
CAM1-F2 TGGCGAACCAAAGGAAATTGTTGACGGTAAGGTCTTAAAACGGATCCCCGGGTTAATTAA 
knock-in_URA3_fw ATTTATGGTGAAGGATAAGTTTTGACCATCAAAGAAGGTTAGCTTGTCTGTAAGCGGATG 
knock-in_URA3_rev GAAGCTTTTTCTTTCCAATTTTTTTTTTTTCGTCATTATACATGTTCTTTCCTGCGTTATCC 
PHO8 +708 TGGAAGAGATTTAATCGATGAG 
PHO8-R1 ATTAAATAATATGTGAAAAAAGAGGGAGAGTTAGATAGGAGAATTCGAGCTCGTTTAAAC 
SEC63-F2 CGATACGGATACAGAAGCTGAAGATGATGAATCACCAGAACGGATCCCCGGGTTAATTAA 
TEF4-F2 TGGCGAAGATAAGGAAATTGTTGACGGTAAGGTTTTGAAACGGATCCCCGGGTTAATTAA 
URApart2_fw TTGTGAGTTTAGTATACATGC 
URApart1_rev ATTCGGTAATCTCCGAACAG 
YNM3-F2 GATTGAAAAGGAATTTACCGGCAACAGCCAAAGTGAAAAACGGATCCCCGGGTTAATTAA 
qPCR oligos  
PTR2_fw CGTTGGTAACAGAGACAGTGC 
PTR2_rev CTGGTCGGCAATCAACACG 
ROQ1_fw TCAATAACCAGCCTACACAGC 
ROQ1_rev GCTTGTGTTTTCCTGTATGCC 
TAF10_fw GGATCAGGTCTTCCGTAGCG 
TAF10_rev AGGCTGTTGCTGTCCTTGC 
 
Table 4. Antibodies 
Antibody Dilution for western blot Source/Supplier Catalogue no. 
Primary antibodies    
anti-FLAG (M2) mouse  1:5,000 Sigma F1804 
anti-GFP (7.1/13.1) mouse  1:5,000 Roche 11814460001 
anti-HA (3F10) rat 1:5,000 Roche 11867423001 
anti-HA (6E2) mouse 1:5,000 NEB 2367S 
anti-mCherry (1C51) mouse 1:5,000 Abcam ab125096 
anti-mCherry rabbit 1:5,000 Biovision 5993 
anti-PGK1 mouse 1:50,000 Abcam ab113687 
anti-PHO8 (1D3A10) mouse 1:5,000 Abcam ab113688 
anti-SEC61 rabbit 1:5,000 Peter Walter  
Secondary antibodies    
anti-mouse-HRP goat 1:10,000 Pierce 31432 
anti-rabbit-HRP goat 1:10,000 Pierce 31462 
anti-rat-HRP donkey 1:10,000 Jackson 712035150 
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Table 5. Antibody coupled beads for immunoprecipitation 
Antibody Amount used for IP Source/Supplier Catalogue no. 
anti-FLAG (M2) mouse 
agarose beads  
30 µL / sample Sigma A2220 
anti-HA (HA-7) mouse 
agarose beads 
30 µL / sample Sigma A2095 
 
Table 6. Enzymes 
Enzyme Supplier 
FastAP alkaline phosphatase Thermo Fisher Scientific 
Gibson Assembly Master Mix New England Biolabs 
HiFi DNA Assembly Master Mix New England Biolabs 
Optitaq DNA polymerase Roboklon 
Phusion® High-Fidelity DNA polymerase New England Biolabs 
Enzyme Supplier 
Q5 High-Fidelity DNA polymerase New England Biolabs 
Restriction enzymes New England Biolabs, Thermo Fisher Scientific 
RevertAid reverse transcriptase Thermo Fisher Scientific 
SensiFAST SYBR No-ROX mix Bioline 
T4 DNA ligase Thermo Fisher Scientific 
Taq polymerase Sigma-Aldrich 
hTaq polymerase Lab collection 
 
Table 7. Standards and kits 
Standards and kits Supplier 
BCA kit Thermo Fisher Scientific 
GeneRuler 1kb Plus DNA Ladder Thermo Fisher Scientific 
NucleoSpin Plasmid Mini-Prep Kit Macherey-Nagel 
NucleoSpin Gel and PCR Clean.up Macherey-Nagel 
PageRuler Plus Prestained Protein 
Ladder 
Thermo Fisher Scientific 
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Table 8. Growth media  
Media Composition 
Lysogeny broth (LB) ampicillin medium 1% (w/v) tryptone 
 0.5% (w/v) yeast extract 
 1% (w/v) NaCl 
 100 µg/mL ampicillin 
  
Synthetic complete (SC) medium  0.69% (w/v) yeast nitrogen base (with ammonium sulphate) 
 2% (w/v) glucose 
 0.2% (w/v) desired amino acid mixture* 
  
Synthetic complete raffinose (SC Raf) 
medium 
0.69% (w/v) yeast nitrogen base (with ammonium sulphate) 
 2% (w/v) raffinose 
 0.2% (w/v) desired amino acid mixture* 
  
Synthetic complete raffinose/galactose 
(SC Raf/Gal) medium  
0.69% (w/v) yeast nitrogen base (with ammonium sulphate) 
 2% (w/v) raffinose 
 2% (w/v) galactose 
 0.2% (w/v) desired amino acid mixture* 
  
Yeast peptone dextrose (YPD) medium 1% (w/v) yeast extract 
 2% (w/v) peptone 
 2% (w/v) glucose 
 
Table 9. Plates 
Plates Composition 
LB ampicillin plates 1% (w/v) tryptone 
 0.5% (w/v) yeast extract 
 1% (w/v) NaCl 
 2% (w/v) agar 
 100 µg/mL ampicillin 
  
SC plates 0.69% (w/v) yeast nitrogen base (with ammonium sulphate) 
 0.2% (w/v) desired amino acid mixture* 
 2% (w/v) glucose 
 2% (w/v) agar 
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Plates Composition 
SC (-HIS/ARG/LYS) plates for SGA 
0.17% (w/v) yeast nitrogen base (without amino acids and 
ammonium sulphate) 
 0.1% (w/v) monosodium glutamate 
 0.2% (w/v) desired amino acid mixture* 
 2% (w/v) glucose 
 2% (w/v) agar 
 50 µg/mL canavanine 
 50 µg/mL thialysine 
  
SC (-HIS/ARG/LYS/URA) Raf/Gal plates 
for SGA 
0.17% (w/v) yeast nitrogen base (without amino acids or 
ammonium sulphate) 
 0.1% (w/v) monosodium glutamate 
 0.2% (w/v) desired amino acid mixture* 
 2% (w/v) raffinose 
 2% (w/v) galactose 
 2% (w/v) agar 
 50 µg/mL canavanine 
 50 µg/mL thialysine 
  
SC (-HIS/ARG/LYS) 5-FOA plates for 
SGA 
0.17% (w/v) yeast nitrogen base (without amino acids or 
ammonium sulphate) 
 0.1% (w/v) monosodium glutamate 
 0.2% (w/v) desired amino acid mixture* 
 1 mg/mL 5-FOA 
 2% (w/v) glucose 
 2% (w/v) agar 
 50 µg/mL canavanine 
 50 µg/mL thialysine 
  
Sporulation plates 0.1% (w/v) yeast extract 
 1% (w/v) potassium acetate 
 0.01% (w/v) amino acid supplement† 
 0.05% (w/v) glucose 
 2% (w/v) agar 
  
YPD plates 1% (w/v) yeast extract 
 2% (w/v) peptone 
 2% (w/v) glucose 
 2% (w/v) agar 
 ________________________________________  MATERIALS AND METHODS 
71 
 
Plates Composition 
YPD G418 plates 1% (w/v) yeast extract 
 2% (w/v) peptone 
 2% (w/v) glucose 
 2% (w/v) agar 
 200 µg/mL geneticin (G418) 
  
YPD hph plates 1% (w/v) yeast extract 
 2% (w/v) peptone 
 2% (w/v) glucose 
 2% (w/v) agar 
 300 µg/mL hygromycin B 
  
YPD nat plates 1% (w/v) yeast extract 
 2% (w/v) peptone 
 2% (w/v) glucose 
 2% (w/v) agar 
 100 µg/mL nourseothricin (ClonNat) 
 
*synthetic complete amino acid mixture is made up as follows: 
Component Amount Component Amount 
adenine 0.5 g isoleucine 2 g 
alanine 2 g leucine 4 g 
para-aminobenzoic acid 0.2 g lysine 2 g 
arginine 2 g methionine 2 g 
asparagine 2 g phenylalanine 2 g 
aspartic acid 2 g proline 2 g 
cysteine 2 g serine 2 g 
glutamic acid 2 g threonine 2 g 
glutamine 2 g tyrosine 2 g 
glycine 2 g tryptophan 2 g 
histidine 2 g uracil 2 g 
inositol 2 g valine 2 g 
Drop out variants of amino acid mixtures follow the same recipe without the desired 
amino acid(s).  
† amino acid supplement is made up as follows: 
Component Amount 
histidine 2 g 
leucine 4 g 
lysine 2 g 
uracil 2 g 
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Table 10. Buffers and solutions 
Buffers, solutions Composition 
1NM-PP1 3 mM in DMSO 
  
Acrylamide mix (30%) 29.2% (w/v) acrylamide 
 0.8% (w/v) N,N’-methylenbisacrylamide (ratio 37.5:1) 
  
Acrylamide mix (49.5%) 46.5% (w/v) acrylamide  
 3.0% (w/v) bisacrylamide (ratio 15.5:1) 
  
Amino acid mix (10x) 20 g/L amino acid mixture in water 
  
Ammonium persulfate (10x) 10% (w/v) in water 
  
Ampicillin 100 mg/mL in water 
  
Anode buffer (5x) 1 M Tris-HCl pH 8.9 
  
Blocking buffer (1x) for western blot 10 mM Tris-HCl pH 7.4 
 150 mM NaCl 
 0.1% (v/v) Tween-20 
 5% (w/v) nonfat dry milk 
  
Blotting buffer (1x) 25 mM Tris 
 192 mM glycine 
 20% (v/v) methanol 
  
Canavanine 50 mg/mL in water 
  
Cathode buffer (5x) 500 mM Tris 
 500 mM Tricine 
 0.5% (v/v) SDS 
  
Colony PCR buffer (10x) 200 mM Tris pH 8.8 
 100 mM (NH4)2SO4 
 100 mM KCl 
 25 mM MgCl2 
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Buffers, solutions Composition 
Complete protease inhibitors mix (25x) 1 tablet in 2mL 0.1 M Na3PO4 pH 7.0 
  
p-Coumaric acid 90 mM in DMSO 
  
Cycloheximide 50 mg/mL in DMSO 
  
DNA loading dye (6x) 50% (v/v) glycerol 
 10% (v/v) 10x TBE buffer 
 0.05% (w/v) Orange G 
  
dNTPs 10 mM of each nucleotide in water 
  
Dithiothreitol (DTT) 1M in water 
  
ECL solution (1x) 100 mM Tris pH 8.5 
 1.25 mM Luminol 
 0.198 mM p-Coumaric acid 
 0.9% (v/v) H2O2 add just before use 
  
β-estradiol 1 mM in ethanol 
  
Galactose (10x) 20% (w/v) in water 
  
Geneticin (G418) 200 mg/mL in water 
  
Glucose (10x) 20% (w/v) in water 
  
Hygromycin B 100 mg/mL in water 
  
Lithium acetate 1 M in water 
  
Luminol 250 mM in DMSO 
  
Lysis buffer (1x) for cell lysis 50 mM Tris-HCl pH7.5 
 0.5 mM EDTA 
 add 1 mM PMSF just before use 
 add 1x complete protease inhibitors just before use 
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Buffers, solutions Composition 
Lysis buffer (1x) for immunoprecipitation 25 mM HEPES pH 7.5 
 100 mM NaCl 
 0.5 mM EDTA 
 10% glycerol 
 0.1% NP-40 
 add 1 mM PMSF just before use 
 add 1x complete protease inhibitors just before use 
  
Lysis buffer (1x) for subcellular fractionation 50 mM HEPES-HCl pH 7.5 
 1 mM EDTA 
 200 mM sorbitol 
 add 1 mM PMSF just before use 
 add 1x complete protease inhibitors just before use 
  
MG132 40mM in DMSO 
  
Nourseothricin (ClonNat) 100 mg/mL in water 
  
PEG 3350 50% (w/v) in water 
  
Phenylmethylsulfonyl fluoride (PMSF) 1 M in DMSO 
  
Ponceau S 0.1% (w/v) Ponceau S 
 5% (v/v) acetic acid 
  
Raffinose (10x) 20% (w/v) in water 
  
Rapamycin 0.2 mg/mL in DMSO 
  
Reducing buffer (1x) for spheroplasting 100 mM Tris-HCl pH 9.4 
 add 10 mM NaN3 just before use 
  
Reducing buffer with DTT (1x) for 
spheroplasting 
100 mM Tris-HCl pH 9.4 
 add 10 mM NaN3 just before use 
 add 10 mM DTT just before use 
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Buffers, solutions Composition 
Running buffer (1x) 0.1% (w/v) SDS 
 25 mM Tris 
 192 mM glycine 
  
Salmon sperm DNA 10 mg/mL in water 
  
Sample buffer (4x) 278 mM Tris-HCl pH 6.8 
 44.4% (v/v) glycerol 
 4.4% (w/v) LDS 
 0.02% bromophenol blue 
 add 10% (v/v) β-mercaptoethanol just before use  
  
Separating gel buffer (1x) 2 M Tris-HCl pH 8.8 
  
Solution B (3x) 3 M Tris-HCl pH 8.5 
 0.3% SDS 
  
Spheroblast buffer (1x) 50 mM Tris-HCl pH 7.5 
 1 M sorbitol 
 add 1 mM PMSF just before use 
 add 1x complete protease inhibitors just before use 
  
Stacking gel buffer (1x) 0.5 Tris-HCl pH 6.8 
  
TAE buffer (50x) 2 M Tris 
 1 M acetic acid 
 50 mM EDTA 
  
TBE buffer (10x) 1 M Tris 
 1 M boric acid 
 0.02 M EDTA 
  
TBS-T buffer (1x) 10 mM Tris-HCl pH 7.4 
 150 mM NaCl 
 0.1% (v/v) Tween-20 
  
TES buffer (1x) 10 mM Tris-HCl pH 7.5 
 10 mM EDTA 
 0.5% SDS 
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Buffers, solutions Composition 
Thialysine 50 mg/mL 
  
Transformation mix 33.33 % (w/v) PEG 3350  
 100 mM Lithium acetate 
 0.27 mg/mL freshly boiled salmon sperm DNA 
  
Tunicamycin 1 mg/mL in DMSO 
  
Zymolyase T20 50 mg/mL zymolyase T20 (1 U/µL) 
 50 mM Tris-HCl pH 7.5 
 
4.2 Molecular biology methods 
All methods were performed according to the standard lab protocols unless noted 
otherwise. 
4.2.1 Plasmids 
Plasmids used in the study are listed in Table 1. The Pho8* constructs contain the 
luminal domain (60-550) of the vacuolar phosphatase Pho8 with two point mutations. 
The F352S mutation is responsible for its degradation phenotype while the N247D 
mutation is irrelevant. CPY* constructs contain the full-length vacuolar carboxy 
peptidase Prc1 with the destabilizing G255R mutation. The Hmg2-GFP plasmid 
contains residues 1-671 of Hmg2. CFTR plasmids contain the full-length human cystic 
fibrosis transmembrane conductance regulator sequence. The Luciferase(WT)-
mCherry and the Luciferase(DM)-mCherry plasmids contain the wild-type or the double 
mutant (R188Q, R261Q) versions of the firefly luciferase respectively. The stGnd1-
mCherry construct contains residues 1-150 of the phosphogluconate dehydrogenase 
Gnd1.  
4.2.2 Molecular cloning 
Plasmids were isolated from chemically competent Escherichia coli DH5α strain using 
the mini-prep kit from Macherey-Nagel and following the manufacturer’s manual. 
Oligos used for cloning and yeast manipulations (Table 3), were synthesized by 
Sigma-Aldrich or Integrated DNA Technologies (IDT). Home-made hTaq or Sigma Taq 
polymerase was used for polymerase chain reactions (PCR) from bacteria or yeast 
colonies. For standard PCR reactions OptiTaq (Roboklon), Q5 (NEB) or Phusion 
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(NEB) DNA polymerase was employed. Amplified DNA products were purified from 
0.7% agarose gels using the NucleoSpin Gel and PCR Clean-up kit (Macherey-Nagel) 
following the manufacturer‘s manual. For molecular cloning, amplified inserts with 
homologues ends to linearized recipient vectors were mixed in a 1:2 molar ratio and 
ligated with the NEBuilder HiFi DNA assembly mix. Point mutations were introduced 
according to the manufacturer’s manual of Quikchange site-directed mutagenesis kit 
(Stratagene). Deletions were introduced by inverse PCR of vectors with primers 
removing the desired sequences and enabling re-ligation of homologues ends. The 
generated constructs were transformed into competent bacteria according to the 
standard lab protocol. The candidate clones were screened by bacterial colony PCR 
and confirmed by sequencing using GATC or SeqLab.  
4.3 Yeast methods 
4.3.1 Yeast strains 
Yeast strains used in the study are listed in Table 2. Unless noted otherwise the strains 
were derived from the Saccharomyces cerevisiae W303 mating type a (SSY122). 
Chromosomal modifications including gene tagging, deletions and integrations were 
achieved by homologous recombination. The desired chromosomal modifications, with 
a selective marker, were introduced into the chromosome using PCR products (Janke 
et al., 2004) or linearized integrative plasmids via flanking homologues sequences 
(Taxis and Knop, 2006). Gene tagging or deletion was confirmed by yeast colony PCR 
using primers that bind in the selection cassette and up- or downstream of the desired 
locus in the chromosome. Single copy chromosomal integrations were identified using 
flow cytometry or western blot. The F352S mutation was introduced into the PHO8 
gene using a PCR product including the Pho8(136-567) sequence with the F352S 
mutation, the kanamycin resistance cassette and flanking homologues regions to 
target it into the PHO8 locus (Schuck et al., 2014). To generate strains SSY2323 and 
SSY2324 the sequence encoding Ub-Roq1∆21-HA(74) or Roq1(R22A)∆21-HA(74) 
together with the URA3 gene was amplified from pSS764 and pSS927 using primers 
knock-in_URA_fw and knock-in_URA_rev and integrated into the ura3 locus of 
SSY792. To generate the strains containing chromosomally integrated Ub-X-mCherry-
sfGFP the constructs from plasmids pAK146-160, pMaM46-48 or pMaM66-67 were 
amplified with primers URApart2_fw and URApart1_rev and integrated into the URA3 
locus. The analogue sensitive tpk1/2/3-as strain contains the following point mutations: 
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TPK1(M164G), TPK2(M147G) and TPK3(M165G) (Hao and O’Shea, 2012). The 
temperature sensitive cdc48-3 allele contains two point mutations (P257L and R387K) 
in the Cdc48 protein (Verma et al., 2011).  
4.3.2 Growth conditions 
Yeast cells were cultured at 30°C in SC, SC -URA or SC -LEU media where uracil or 
leucine selection was required to maintain plasmid selection. In general experiments 
were performed in mid-log growth phase between OD600 0.5-1 (in short OD from now 
on) unless noted otherwise. Cells were inoculated in liquid media for 5-10 hours (“pre-
culture”), followed by diluting back to reach mid-log phase the following morning 
(“overnight culture”). During cycloheximide (CHX) chase, cells in mid-log phase were 
treated with 50 µg/mL cycloheximide (Sigma). In the CHX chase experiments the 
reporters harboured the fast folding superfolder GFP (sfGFP), (Pédelacq et al., 2006) 
instead of regular GFP. Since sfGFP folds in ~5 minutes the last reporter molecules, 
with the sfGFP fluorophore generated prior to addition of cycloheximide will be 
detected shortly after inhibiting protein translation. This enabled us to reduce the side 
effect coming from the slower maturation kinetics of GFP and thus a slight increase in 
GFP fluorescence after CHX treatment. During ER-stress experiments, cells in mid-log 
phase were diluted back to OD 0.05 and treated with tunicamycin (1 µg/mL for western 
blot experiments and 2 µg/mL for flow cytometry assays, Merck) or 8mM dithiothreitol 
(DTT) (Applichem) (Cleland, 1964; Takatsuki et al., 1971). To inhibit serine proteases, 
PMSF (Fahrney and Gold, 1963) was used at 1 mM final concentration, while inhibiting 
the proteasome was achieved by MG132 (Merck) at 80 µM (Rock et al., 1994). For 
efficient inhibition of the proteasome a strain lacking the plasma membrane ABC 
transporter PDR5 was used (Leppert et al., 1990). For starvation experiments, cells in 
mid-log phase were diluted back to OD 0.05 and rapamycin (Sehgal et al., 1975) was 
used at a final concentration of 0.2 µg/mL. For growth into post-diauxic phase, cells in 
mid-log phase were normalized to OD 0.5 and were grown for 24 hours. To inhibit the 
PKA homologue Tpk1/2/3, the analogue sensitive tpk1/2/3-as cells in mid-log phase 
were diluted back to OD 0.05 and treated with 1NMPP-1 at a final concentration of 
3 µM (Merck). To activate the Gal4-Estrogen-Receptor-Msn2 (GEM) chimeric 
transcription factor, β-estradiol (Sigma) was used in the final concentration of 400 nM 
for 6 hours for flow cytometry experiments and 8 hours for mass spectrometry analysis. 
To induce expression with galactose, cells were inoculated from plates into SC Raf 
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medium for 5-10 hours followed by diluting back to reach OD 0.2 the following morning. 
Galactose was supplemented to a final concentration of 2% and cells were grown for 
an additional 2 hours. Two hours of promoter induction by galactose resulted in a 
comparable expression level to the constitutive ADH1 promoter. Promoter shut-off was 
achieved by diluting the cells back to SC medium in a 1:9 ratio. As in the CHX chase 
experiments (see above), GAL1-driven reporters harboured sfGFP instead of regular 
GFP. 
4.3.3 Flow cytometry 
The flow cytometry experiments were performed in 96-well deep-well plates. Saturated 
pre-cultures were diluted back to OD 0.02 in 1 mL medium and were placed in a 
programmable incubator (Memmert, “Jesus”). The incubator kept the temperature at 
14°C until midnight, followed by increasing the temperature to 30°C to reach the 
desired OD the following morning. Cells in mid-log phase were normalized to OD 0.05 
in 1 mL medium containing the appropriate drug or left untreated (see “yeast culture” 
for details on treatments) and were grown at 30°C for the indicated time. At each time 
point 100 μL of sample was measured for fluorescence and cell number with the FACS 
Canto (BD Biosciences) flow cytometer equipped with a high-throughput sampler. In 
order to determine the reporter levels, the mean GFP fluorescence was corrected for 
autofluorescence by subtracting the fluorescence values measured in identically 
treated control cells without any GFP-tagged proteins. The corrected GFP values were 
normalized to cell volume by dividing it with the mean fluorescence of a constitutively 
expressed cytosolic BFP fluorophore. To assess the effect of different stressors, the 
GFP/BFP ratios in treated cells were divided by the corresponding ratios in non-treated 
cells. Finally, the reporter levels were plotted in percent of the levels at time point 0. In 
the cycloheximide chase experiments total GFP fluorescence was determined by 
multiplying mean GFP fluorescence by cell number and the values were plotted in 
percent of the levels at time point 0.  
4.3.4 Transformation of yeast 
A saturated overnight culture in YPD media was diluted back to OD 0.4 in 5 mL YPD 
and was grown for 4 hours at 30°C to reach approximately OD 1. Cells were pelleted 
at 1,000 g for 5 minutes and the pellet was washed in 5 mL water. Cells were pelleted 
again and transferred to a microcentrifuge tube in 1 mL water. After centrifugation at 
10,000 g for 2 minutes the supernatant was completely removed. Transforming DNA 
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(1/10th of a purified PCR product, ~250 ng of linearized integrative plasmid or ~25-100 
ng of episomal plasmids) was added directly to the cell pellet followed by resuspending 
the pellet in 360 µL freshly prepared transformation mix. The reaction mix per sample 
contained the following components: 
Constituent Volume 
50% (w/v) PEG 3350 240 µL 
1 M lithium acetate 36 µL  
10 mg/mL salmon sperm DNA 10 µL  
ddH2O 74 µL 
Transformation was performed at 42°C for 40 minutes. Afterwards cells were pelleted 
at 10,000 g for 2 minutes and resuspended in 1 mL YPD. Transformants with 
auxotrophic selection markers were plated on selective plates directly after 
transformation while transformants with antibiotic selection markers were grown for 4-
6 hours at 30°C before plating them on selection plates. Plates were incubated at 30°C 
until visible colonies were formed.  
4.3.5 Yeast cell lysis 
Cells were pelleted by centrifugation at 1,000g for 5 minutes at 4°C followed by 
resuspending in 1 mL cold water and transferring to a microcentrifuge tube to pellet 
again. After careful removal of the supernatant, cell pellets were resuspended in 
200 µL cold lysis buffer supplemented with PMSF and complete protease inhibitors 
(Roche) and transferred to 2 mL screw-cap tubes with 0.7 g of 1 mm glass beads. Cells 
were disrupted using FastPrep 24 (MP Biomedicals) for 40 seconds at 6.0 m/s. 
Proteins were solubilized by addition of 1.5% SDS and incubation at 65°C for 
5 minutes. Lysates were clarified at 16,000 g for 2 minutes at 4°C.  
4.3.6 Generation of spheroplasts for subcellular fractionation 
In order to preserve the reticulon-based reporters in the ER membranes we employed 
a gentler cell lysis method, which included generation of spheroplasts (yeast cells 
without cell wall). Cells in mid-log phase were pelleted by centrifugation at 1,000g for 
5 minutes at room temperature (RT) followed by resuspending in 4 mL reducing buffer 
containing freshly added 10 mM NaN3 to kill the cells. After pelleting again at RT, cells 
were resuspended in 4 mL reducing buffer containing freshly added 10 mM NaN3 and 
10 mM DTT to break disulfide bonds in the cell wall to ensure efficient zymolyase 
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treatment. Cells were pelleted and resuspended in 1 mL spheroplast buffer containing 
zymolyase T20 at a final concentration of 0.2 U/OD. In order to monitor the conversion 
to spheroplasts, 25 µL of cells were diluted in 975 µL water and the initial OD was 
determined. Cells were incubated at 30°C for 10 minutes. If spheroplasting was 
successful, osmotic lysis occurs when spheroplasts are diluted in water and the OD 
should drop below 10% of the initial value. Spheroplasts were collected by 
centrifugation at 1,000 g for 5 minutes at 4°C. Supernatant was carefully removed and 
the pellet was gently washed three times with 1 mL cold spheroplast buffer to ensure 
complete removal of zymolyase.  
4.3.7 Yeast spotting assay 
Cells in mid-log phase were diluted back to OD 0.2 in 1 mL YPD and a dilution series, 
with five-fold dilution steps, were prepared in a flat bottom 96-well plate. Using a 
manual pinning tool, the cells were spotted on YPD agar plates. Plates were incubated 
at 30°C until visible colonies were formed.  
4.3.8 Liquid growth assay 
Cells in mid-log phase were diluted back to OD 0.05 in 500 μL SC containing 400 nM 
estradiol or left untreated. Cells were seeded in a 48-well plate. Absorbance was 
measured at 600 nm for ~24 hours in 5-minute intervals with the Tecan Infinite M1000 
Pro machine. A shaking routine consisting of 120 s orbital shaking, 30 s rest and 90 s 
linear shaking was used to keep cells in suspension between OD measurements. Area 
under the curve (total growth) was determined using the R package “Growthcurver” 
(Sprouffske and Wagner, 2016).  
4.3.9 Light microscopy 
Cells in mid-log phase were imaged at RT with a spinning disk confocal microscope 
(Nikon TE2000 inverted microscope). The acquired images were processed by Adobe 
Photoshop.  
4.3.10 RNA preparation 
RNA was isolated from cells by phenol/chloroform extraction. Briefly, 5 ODs of cells 
were harvested from mid-log phase by centrifugation at 1,000 g for 5 minutes at 4°C. 
After washing the pellets once with cold water, the pellets were resuspended in 400 μL 
TES buffer. Afterwards, 400 μL of water-saturated phenol was added and vortexed 
vigorously for 10 seconds. The mixture was incubated at 65°C for 60 minutes and 
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vortexed every 10 minutes for 10 seconds. Phase separation was induced by 
centrifugation at 16,000 g for 5 minutes at 4°C. The aqueous top phase was collected 
to a fresh microcentrifuge tube. RNA was extracted twice more with 400 μL phenol and 
once with 400 μL chloroform. RNA was precipitated by addition of 40 μL 3M NaOAc 
pH 5.3 and 1 mL of cold 100% ethanol. RNA was pelleted by centrifugation at 16,000 g 
for 5 minutes at 4°C and washed once with 1 mL cold 70% ethanol. After the complete 
removal of ethanol, the pellet was resuspended in 30 μL water and RNA concentration 
was determined with NanoDrop.  
4.3.11 Tandem fluorescence timer (tFT) screen 
The tFT library was constructed in the yMaM330 strain where 4081 pre-selected ORFs 
were tagged with a tFT tagging module on the C-terminus (Khmelinskii et al., 2014). 
The module contains the following elements in this order: mCherry, I-SceI cut site, 
CYC1 terminator, URA3 selection marker, second I-SceI cut site, mCherry∆N-sfGFP 
(C-terminal fragment of mCherry followed by sfGFP). Induced expression of the I-SceI 
endonuclease allows the removal of both the CYC1 terminator and the URA3 gene 
and induces homologues recombination to generate the full tFT tag. This seamless 
tagging approach reduces the negative impact of introducing excessive amount of 
foreign genetic material into the chromosome. Moreover, it maintains the expression 
of gene fusions under the control of endogenous up- and downstream regulatory 
elements. 
The following query strains were mated against the entire tFT library: SSY1588 (ura3∆) 
and SSY1590 (roq1∆). Additionally, the top 56 hits from a tFT screen aimed to find 
endogenous UBR1 substrates (performed by Anton Khmelinskii) were manually 
arrayed on an extra plate and mated with SSY1475 (ynm3∆). Each array plate also 
contained a negative and a positive control, SSY552 (Rtn1-tFT + p316) and SSY553 
(Rtn1Pho8*-tFT + p316) respectively. The p316 plasmid was required for selection on 
SC -URA plates. Mass mating and sequential steps in the synthetic genetic array 
(SGA) analysis (Tong and Boone, 2005) were performed using the Singer ROTOR 
HDA (Singer Instruments) colony-arraying robot. The SGA procedure is summarized 
below and the individual steps are listed in Table 12: 
1. Mating of the query strains with the tFT library 
Saturated cultures of the query strains were arrayed into a 384 colony/plate 
format on YPD plates to match the density of the tFT library. The MATa query 
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strains were pinned on a new YPD plate and the strains from the MATα tFT 
library were directly pinned on top to allow mating to occur. Plates were 
incubated at 30°C overnight. 
2. Diploid selection 
MATa/α diploids were selected on YPD G418/nat plates. This selection 
eliminated unmated haploid cells. 
3. Sporulation 
Diploid cells were pinned onto sporulation plates and were incubated for 7 days 
at 20°C to let cells undergo meiosis and produce spores. 
4. Mating type selection 
After sporulation haploid spores with MATa were selected by pinning them on 
SC (-HIS/ARG/LYS) plates. The selection was achieved by using a MATa 
specific STE2 promoter that drives the expression of the Schizosaccharomyces 
pombe HIS5 gene. Additionally, the mating type selection cassettes were 
integrated into the CAN1 and LYP1 loci that encode plasma membrane arginine 
and lysine permeases respectively. Addition of toxic arginine and lysine 
analogues to the media (canavanine and thialysine respectively) results in 
selection for cells containing the mating type selection cassettes 
(can1∆::STE2pr-SpHIS5 lyp1∆::STE3pr-LEU2).  
5. Allele selection 
After selection for MATa spores we selected for all the desired alleles in a step-
wise manner. In brief, first we selected for the tFT tag, followed by selection for 
the knockout, BFP and finally the endonuclease. 
6. Excision of the URA3 marker and generating the full tFT tag 
In order to generate the full tFT tag the I-SceI endonuclease had to be 
expressed. The endonuclease was placed under the inducible GAL1 promoter 
thus pinning the cells on SC RAF/GAL plates initiated endonuclease 
expression, excision of the URA3 selection marker gene and generation of the 
full tFT tag via homologues recombination. This step was repeated twice.  
7. Full tFT tag selection 
The cleavage by endonuclease removed the URA3 selection cassette. To 
successfully select for cells that lost the URA3 marker we pinned the cells on 
plates containing 5-fluoroorotic acid (5-FOA). 
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Table 12. Plates used during SGA 
SGA steps Plates 
Mating YPD 
Diploid selection YPD + G418/nat 
Sporulation Sporulation plates 
Mating type selection SC (-HIS/ARG/LYS) + can/thia 
tFT selection SC (-HIS/ARG/LYS/URA) + can/thia 
KO selection SC (-HIS/ARG/LYS/URA) + can/thia/G418 
BFP selection SC (-HIS/ARG/LYS/URA) + can/thia/G418/hph 
Endonuclease selection SC (-HIS/ARG/LYS/URA) + can/thia/G418/hph/nat 
Excision of the URA3 marker SC (-HIS/ARG/LYS) RAF/GAL + can/thia/G418/hph/nat 
Full tFT tag selection SC (-HIS/ARG/LYS) + can/thia/5-FOA 
Final selection SC (-HIS/ARG/LYS) + can/thia/G418/hph/nat 
Screening SC 
 
The screening was performed on SC plates after ~20-24 hours of growth. On each 
screening plate (total of 77 plates in 1536 colony/plate format) the identical tFT-tagged 
strains from the ura3∆ (control) and roq1∆ SGA were pinned next to each other 
together with control strains expressing no fluorophores (autofluorescence control, 
SSY765) and reference strains. The reference strains included tFT protein fusions with 
a broad range of protein half-life. The same reference strains were used on each 
screening plate in order to remove any plate-to-plate variation. Fluorescence 
intensities from colonies were measured by the Tecan Infinite M1000 Pro microplate 
reader. Following the screen, each screening plate was imaged by Gel Doc XR+ 
(BioRad). 
4.3.12 Quantification and validation of the tFT screen 
An R script, written in the Knop lab, was used to quantify the data from the tFT screen. 
In brief, yeast colonies were segmented from the plate images to determine locations 
with empty slots and abnormal colony shapes. In order to remove spatial effects of 
screening plates, sfGFP and mCherry fluorescence was corrected locally according to 
the reference colonies. In order to correct for autofluorescence, mCherry and sfGFP 
intensities were corrected by subtracting fluorescence values from strains expressing 
no fluorophores. Finally, to remove any plate-to-plate variations mCherry and sfGFP 
values were rescaled according to the intensities from the reference colonies in all 
77 plates. 
 ________________________________________  MATERIALS AND METHODS 
85 
 
Candidate substrates were selected where the mCherry/sfGFP ratio difference 
between roq1∆ and ura3∆ strains is higher than log2 0.2 (p< 0.1). This filtering resulted 
in a total of 332 candidate substrates. In order to validate the hits 152 candidates were 
re-screened in liquid culture with flow cytometry. In brief, saturated pre-cultures in 96-
well plates were diluted back to OD 0.05 in 1 mL SC and measured 5 (log phase) and 
24 hours (diauxic phase) later with FACS Canto flow cytometer equipped with a high-
throughput sampler.  
4.3.13 Mass spectrometry (analysis was performed by Daniel Itzhak and Georg 
Borner) 
The following strains were used for mass spectrometry analysis: SSY1488 (WT), 1559 
(WT + Roq1 OE), 2143 (ubr1∆) and 1561 (ubr1∆ + Roq1 OE). Cells were grown to 
mid-log phase and diluted back to OD 0.05 followed by treatment with 400 nM estradiol 
for 8 hours. Three ODs of cells were harvested and lysed as described above (“yeast 
cell lysis”) except that PMSF was not used. Lysates were processed and analysed on 
a Q Exactive HF Hybrid Quadrupole-Orbitrap mass spectrometer (Itzhak et al., 2016). 
Full proteomes of the four strains were analysed from four biological replicates. For 
each identified protein the difference between WT and WT + Roq1 OE was determined 
and averaged over the four replicates. Candidate SHRED substrates were selected 
whose levels in WT + Roq1 OE cells were at least 0.75 fold lower compared to WT 
cells and whose protein levels in ubr1∆ and ubr1∆ + Roq1 OE cells were similar 
(between 0.9 and 1.1 fold). These selected thresholds were based on the observed 
change in GFP and Pho8 levels that served as positive control. All differences were 
subjected to a paired, one-tailed t-test and filtered by false discovery rate (FDR)-
controlled analysis.  
4.4 Biochemistry methods 
4.4.1 Subcellular fractionation 
Spheroplasts were resuspended in 900 µL lysis buffer and 500 µL were transferred 
into a 2 mL Dounce homogenizer with a tight-fitting pestle B (clearance 0.01 – 
0.06 mm). Cells were disrupted with 20 strokes and the lysate was transferred to a 
fresh microcentrifuge tube. Lysates were cleared at 500 g for 5 minutes at 4°C and 
400 µL lysate was removed without disturbing the pellet. 200 µL was set aside as total 
(T) and the remaining 200 µL was centrifuged at 16,000 g for 15 minutes at 4°C. 
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Supernatant (S) was collected and set aside. The pellet (P) was resuspended in 200 µL 
cold lysis buffer. Proteins in total (T), supernatant (S) and pellet (P) fraction were 
solubilized by addition of 1.5% SDS and incubation at 65°C for 5 minutes. Equal 
volumes were resolved on a SDS PAGE gel.  
4.4.2 Protein determination 
Total protein concentration was determined using the bicinchoninic acid assay (BCA) 
following the manufacturer’s manual. In brief, a reference serial dilution (0 – 1 µg) of 
bovine serum albumin (BSA) solution was loaded in a 96-well plate in 150 µL water. In 
the sample wells 0.5 – 1 µL of yeast lysate was mixed in a total volume of 150 µL 
water. BCA reagents A and B were mixed in a 1:49 ratio and 150 µL pf mixture was 
added to every well generating a total of 300 µL reaction volume. The plate was 
incubated at 37°C for 15-45 minutes and absorbance was measured at 562 nm with a 
plate reader. Protein concentrations of the samples were calculated based on the 
reference series.  
4.4.3 Western blot 
Equal amounts of protein lysate were resolved on 10% SDS-PAGE or 16% Tris-Tricine 
SDS-PAGE gels. The composition of the gels is listed in Table 13. Proteins were 
resolved using constant 200 V for the SDS-PAGE gels while proteins on Tris-Tricine 
gels were resolved initially at 30 V for 30 minutes followed by 60 minutes at 200 V and 
finally 30 minutes at 300 V. The proteins were transferred to a nitrocellulose membrane 
using wet electroblotting systems (BioRad) for 1 hour at 100 V. Membranes were 
incubated in blocking buffer for 30 minutes and probed overnight with primary antibody. 
The following morning the membranes were rinsed three times with TBST for 5 minutes 
and incubated with horseradish peroxidase (HRP) coupled secondary antibodies for 
1 hour. After rinsing the membranes with TBST three times the membranes were 
incubated with homemade ECL solution and chemiluminescence was detected using 
the ImageQuant LAS 4000 imaging system. The acquired images were quantified by 
Fiji and processed by Adobe Photoshop. Antibodies used in the study are listed in 
Table 4. 
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Table 13. Composition of the SDS-PAGE gels 
Separating gel 
10% SDS-PAGE 16% Tris-tricine SDS-PAGE 
H2O 2.7 mL H2O 1.34 mL 
separating gel buffer 1.2 mL 3x solution B 2 mL 
30% acrylamide mix 2.0 mL 49.5% acrylamide mix 1.94 mL 
15% SDS 40 µL 87% glycerol 0.72 mL 
10% APS 60 µL 10% APS 30 µL 
TEMED 6 µL TEMED 3 µL 
4% stacking gel  
H2O 1.2 mL H2O 1.17 mL 
stacking gel buffer 0.5 mL 3x solution B 0.67 mL 
30% acrylamide mix 0.27 mL 49.5% acrylamide mix 0.16 mL 
15% SDS 13 µL   
10% APS 20 µL 10% APS 20 µL 
TEMED 2 µL TEMED 2 µL 
 
4.4.4. Immunoprecipitation 
Ten ODs of cells in mid-log phase were harvested and lysed as described above in 
lysis buffer for IP supplemented with complete protease inhibitors and 1mM PMSF. 
Lysates were cleared at 12,000g for 10 minutes at 4°C. Roq1∆21-HA(74) or FLAG-
Ubr1 variants were immunoprecipitated with anti-HA or anti-FLAG coupled agarose 
beads for 30 minutes at 4°C. Beads were washed three times with cold lysis buffer and 
boud proteins were eluted using 1X SDS-PAGE sample buffer at 95°C for 5 minutes. 
Six percent of total lysate (~60 μg of protein) served as “input”. Samples were 
separated on 4-15% gradient gels (BioRad) and co-immunoprecipitated proteins were 
detected by anti-FLAG, anti-HA or anti-mCherrry antibody.  
4.4.5. Quantitative real-time PCR (performed by Rolf Schmidt) 
cDNA was synthesized from the isolated mRNA using the Protoscript II synthesis kit 
following the manufacturer’s manual. In brief, RNA samples were normalized to 
167 ng/μL and 3 μL of sample was mixed with 3 μL of mix A (Table 14) followed by 
incubation at 65°C for 5 minutes. cDNA synthesis was initiated by addition of 4 μL 
mix B (Table 14) and incubation at 42°C for 1 hour. The enzyme was inactivated at 
70°C for 5 minutes. qPCR was performed in a 384-well plate format with 
LightCycler II 480 using the SensiFAST SYBR No-ROX kit. For each primer pair a 
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control well with water instead of cDNA was used. Approximately 5 ng of cDNA was 
used per reaction. TAF10 mRNA served as internal control to determine the relative 
amounts of ROQ1 or PTR2 mRNA. Primers for the qPCR reactions are listed in 
Table 3. 
Table 14. Composition of cDNA synthesis mix and qPCR reaction 
Mix A 
Nuclease free water 2.5 μL 
Oligo(dT)18 primer 0.5 μL 
Mix B 
5x reaction buffer 2 μL 
RiboLock RNase inhibitor 0.5 μL 
10 mM dNTP mix 1 μL 
RevertAid M-MuLV reverse transcriptase 0.5 μL 
qPCR reaction 
2x SensiFAST SYBR Green 5 μL 
2.5 µM fw primer 1 μL 
2.5 µM rev primer 1 μL 
cDNA (~5 ng) 3 μL 
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CONTRIBUTION BY CO-WORKERS 
Characterization and mechanistic analysis of the SHRED pathway would not have 
been possible without contribution from co-workers in the Schuck Lab and 
collaborators from the Max Planck Institute of Biochemistry in Martinsried, Germany. 
Hereby, I single out their contributions to the Results section: Sebastian Schuck, 
together with Enrique Garcia-Rivera, Vivian Chen and Dale Muzzey performed the 
random mutagenesis screen. Katharina Schaeff and Kevin Leiss contributed in the 
characterization of both the misfolded reporter protein and the SHRED pathway. Juan 
Diaz-Miyar helped out in the tandem fluorescent timer screen and in the 
characterization of SHRED substrates. Rolf Schmidt and Peter Bircham contributed 
with qPCR and growth assay experiments, respectively. Finally, the mass 
spectrometry analysis was performed by Daniel Itzhak and Georg Borner. 
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